IDEAS home Printed from https://ideas.repec.org/f/c/phu379.html
   My authors  Follow this author

Don Husereau

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Blog mentions

As found by EconAcademics.org, the blog aggregator for Economics research:
  1. Chiranjeev Sanyal & Don Husereau, 2020. "Systematic Review of Economic Evaluations of Services Provided by Community Pharmacists," Applied Health Economics and Health Policy, Springer, vol. 18(3), pages 375-392, June.

    Mentioned in:

    1. Chris Sampson’s journal round-up for 1st June 2020
      by Chris Sampson in The Academic Health Economists' Blog on 2020-06-01 11:00:00
  2. Jaclyn Beca & Don Husereau & Kelvin K. W. Chan & Neil Hawkins & Jeffrey S. Hoch, 2018. "Oncology Modeling for Fun and Profit! Key Steps for Busy Analysts in Health Technology Assessment," PharmacoEconomics, Springer, vol. 36(1), pages 7-15, January.

    Mentioned in:

    1. Don Husereau’s journal round-up for 25th November 2019
      by Don Husereau in The Academic Health Economists' Blog on 2019-11-25 12:00:55

Articles

  1. Don Husereau & Michael Drummond & Federico Augustovski & Esther Bekker-Grob & Andrew H. Briggs & Chris Carswell & Lisa Caulley & Nathorn Chaiyakunapruk & Dan Greenberg & Elizabeth Loder & Josephine Ma, 2022. "Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations," Applied Health Economics and Health Policy, Springer, vol. 20(2), pages 213-221, March.

    Cited by:

    1. Yichen Zhang & Yuxuan Wei & Huangqianyu Li & Yixuan Chen & Yiran Guo & Sheng Han & Luwen Shi & Xiaodong Guan, 2022. "Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China," PharmacoEconomics, Springer, vol. 40(7), pages 715-724, July.
    2. Susanne Mayer & Agata Łaszewska & Judit Simon, 2022. "Unit Costs in Health Economic Evaluations: Quo Vadis, Austria?," IJERPH, MDPI, vol. 20(1), pages 1-12, December.
    3. Siwaporn Niyomsri & Mantiwee Nimworapan & Wanwarang Wongcharoen & Piyameth Dilokthornsakul, 2023. "Economic Evaluation of Direct Oral Anticoagulants Compared to Warfarin for Venous Thromboembolism in Thailand: A Cost-Utility Analysis," IJERPH, MDPI, vol. 20(4), pages 1-15, February.
    4. Chia-Chin Li & Ying-Chun Lin & Ji-An Liang & K. S. Clifford Chao & Te-Chun Hsia & Chun-Ru Chien, 2023. "Health Economic Evaluation of Proton Therapy for Lung Cancer: A Systematic Review," IJERPH, MDPI, vol. 20(6), pages 1-10, March.
    5. Ghislaine van Mastrigt & Caroline van Heugten & Anne Visser-Meily & Leonarda Bremmers & Silvia Evers, 2022. "Estimating the Burden of Stroke: Two-Year Societal Costs and Generic Health-Related Quality of Life of the Restore4Stroke Cohort," IJERPH, MDPI, vol. 19(17), pages 1-15, September.
    6. de Melo Santos, Carlos Jefferson & Sant’Anna, Angelo Marcio Oliveira, 2024. "Evaluation of the public policy impacts on Monkeypox in Brazil," Evaluation and Program Planning, Elsevier, vol. 103(C).

  2. Don Husereau & Michael Drummond & Federico Augustovski & Esther Bekker-Grob & Andrew H. Briggs & Chris Carswell & Lisa Caulley & Nathorn Chaiyakunapruk & Dan Greenberg & Elizabeth Loder & Josephine Ma, 2022. "Correction to: Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations," Applied Health Economics and Health Policy, Springer, vol. 20(5), pages 781-782, September.

    Cited by:

    1. de Melo Santos, Carlos Jefferson & Sant’Anna, Angelo Marcio Oliveira, 2024. "Evaluation of the public policy impacts on Monkeypox in Brazil," Evaluation and Program Planning, Elsevier, vol. 103(C).

  3. Chiranjeev Sanyal & Paul Stolee & Don Juzwishin & Don Husereau, 2018. "Economic evaluations of eHealth technologies: A systematic review," PLOS ONE, Public Library of Science, vol. 13(6), pages 1-11, June.

    Cited by:

    1. Nkiruka D Eze & Céu Mateus & Tiago Cravo Oliveira Hashiguchi, 2020. "Telemedicine in the OECD: An umbrella review of clinical and cost-effectiveness, patient experience and implementation," PLOS ONE, Public Library of Science, vol. 15(8), pages 1-24, August.
    2. Francesco Inchingolo & Angelo Michele Inchingolo & Maria Celeste Fatone & Pasquale Avantario & Gaetano Del Vecchio & Carmela Pezzolla & Antonio Mancini & Francesco Galante & Andrea Palermo & Alessio D, 2024. "Management of Rheumatoid Arthritis in Primary Care: A Scoping Review," IJERPH, MDPI, vol. 21(6), pages 1-35, May.
    3. Krzysztof Płaciszewski & Waldemar Wierzba & Janusz Ostrowski & Jarosław Pinkas & Mateusz Jankowski, 2022. "Use of the Internet for Health Purposes—A National Web-Based Cross-Sectional Survey among Adults in Poland," IJERPH, MDPI, vol. 19(23), pages 1-18, December.
    4. Angélica Baptista Silva & Rondineli Mendes da Silva & Gizele da Rocha Ribeiro & Ana Cristina Carneiro Menezes Guedes & Daniela Lacerda Santos & Carla Cardi Nepomuceno & Rosângela Caetano, 2020. "Three decades of telemedicine in Brazil: Mapping the regulatory framework from 1990 to 2018," PLOS ONE, Public Library of Science, vol. 15(11), pages 1-20, November.

  4. Don Husereau & Anthony Culyer & Peter Neumann & Philip Jacobs, 2015. "How do Economic Evaluations Inform Health Policy Decisions for Treatment and Prevention in Canada and the United States?," Applied Health Economics and Health Policy, Springer, vol. 13(3), pages 273-279, June.

    Cited by:

    1. McDaid, David & Park, A-La & Wahlbeck, Kristian, 2019. "The economic case for the prevention of mental illness," LSE Research Online Documents on Economics 100054, London School of Economics and Political Science, LSE Library.

  5. Lianne Barnieh & Fiona Clement & Anthony Harris & Marja Blom & Cam Donaldson & Scott Klarenbach & Don Husereau & Diane Lorenzetti & Braden Manns, 2014. "A Systematic Review of Cost-Sharing Strategies Used within Publicly-Funded Drug Plans in Member Countries of the Organisation for Economic Co-Operation and Development," PLOS ONE, Public Library of Science, vol. 9(3), pages 1-10, March.

    Cited by:

    1. Liran Einav & Amy Finkelstein & Maria Polyakova, 2016. "Private Provision of Social Insurance: Drug-specific Price Elasticities and Cost Sharing in Medicare Part D," NBER Working Papers 22277, National Bureau of Economic Research, Inc.
    2. Berger, Michael & Pock, Markus & Reiss, Miriam & Röhrling, Gerald & Czypionka, Thomas, 2023. "Exploring the effectiveness of demand-side retail pharmaceutical expenditure reforms: cross-country evidence from weighted-average least squares estimation," LSE Research Online Documents on Economics 116928, London School of Economics and Political Science, LSE Library.
    3. Berger, Michael & Six, Eva & Czypionka, Thomas, 2024. "Policy implications of heterogeneous demand reactions to changes in cost-sharing: Patient-level evidence from Austria," Social Science & Medicine, Elsevier, vol. 340(C).
    4. M. Fasihul Alam & David Cohen & Frank Dunstan & Dyfrig Hughes & Philip Routledge, 2018. "Impact of the phased abolition of co‐payments on the utilisation of selected prescription medicines in Wales," Health Economics, John Wiley & Sons, Ltd., vol. 27(1), pages 236-243, January.
    5. Han, Euna & Chae, Su-Mi & Kim, Nam-Soon & Park, Sylvia, 2015. "Effects of pharmaceutical cost containment policies on doctors’ prescribing behavior: Focus on antibiotics," Health Policy, Elsevier, vol. 119(9), pages 1245-1254.
    6. Laba, Tracey-Lea & Cheng, Lucy & Worthington, Heather C. & McGrail, Kimberlyn M. & Chan, Fiona K.I. & Mamdani, Muhammad & Law, Michael R., 2020. "What happens to drug use and expenditure when cost sharing is completely removed? Evidence from a Canadian provincial public drug plan," Health Policy, Elsevier, vol. 124(9), pages 977-983.
    7. Beatriz Gonzalez Lopez-Valcarcel & Jaume Puig-Junoy & Santiago Rodriguez Feijoó, 2016. "Copagos sanitarios. Revisión de experiencias internacionales y propuestas de diseño," Policy Papers 2016-04, FEDEA.
    8. Berger, Michael & Six, Eva & Czypionka, Thomas, 2024. "Policy implications of heterogeneous demand reactions to changes in cost-sharing: patient-level evidence from Austria," LSE Research Online Documents on Economics 121162, London School of Economics and Political Science, LSE Library.
    9. Rättö, Hanna & Kurko, Terhi & Martikainen, Jaana E. & Aaltonen, Katri, 2021. "The impact of a co-payment increase on the consumption of type 2 antidiabetics – A nationwide interrupted time series analysis," Health Policy, Elsevier, vol. 125(9), pages 1166-1172.
    10. Gourzoulidis, George & Kourlaba, Georgia & Stafylas, Panagiotis & Giamouzis, Gregory & Parissis, John & Maniadakis, Nikolaos, 2017. "Association between copayment, medication adherence and outcomes in the management of patients with diabetes and heart failure," Health Policy, Elsevier, vol. 121(4), pages 363-377.
    11. Jelena Arsenijevic & Milena Pavlova & Bernd Rechel & Wim Groot, 2016. "Catastrophic Health Care Expenditure among Older People with Chronic Diseases in 15 European Countries," PLOS ONE, Public Library of Science, vol. 11(7), pages 1-18, July.

  6. Ake Blomqvist & Colin Busby & Don Husereau, 2013. "Capturing Value from Health Technologies in Lean Times," C.D. Howe Institute Commentary, C.D. Howe Institute, issue 396, December.

    Cited by:

    1. Claude Forget, 2014. "The Case of the Vanishing Quebec Physicians: How to Improve Access to Care," C.D. Howe Institute Commentary, C.D. Howe Institute, issue 410, May.
    2. Åke Blomqvist & Colin Busby, 2016. "The Naylor Report and Health Policy: Canada Needs a New Model," e-briefs 240, C.D. Howe Institute.

  7. Don Husereau & Michael Drummond & Stavros Petrou & Chris Carswell & David Moher & Dan Greenberg & Federico Augustovski & Andrew Briggs & Josephine Mauskopf & Elizabeth Loder, 2013. "Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(3), pages 367-372, June.

    Cited by:

    1. Giovanna Elisa Calabrò & Sara Boccalini & Donatella Panatto & Caterina Rizzo & Maria Luisa Di Pietro & Fasika Molla Abreha & Marco Ajelli & Daniela Amicizia & Angela Bechini & Irene Giacchetta & Piero, 2022. "The New Quadrivalent Adjuvanted Influenza Vaccine for the Italian Elderly: A Health Technology Assessment," IJERPH, MDPI, vol. 19(7), pages 1-14, March.
    2. Christensen, Garret & Miguel, Edward & Sturdy, Jennifer, 2017. "Transparency, Reproducibility, and the Credibility of Economics Research," MetaArXiv 9a3rw, Center for Open Science.
    3. Dyfrig Hughes & Joanna Charles & Dalia Dawoud & Rhiannon Tudor Edwards & Emily Holmes & Carys Jones & Paul Parham & Catrin Plumpton & Colin Ridyard & Huw Lloyd-Williams & Eifiona Wood & Seow Tien Yeo, 2016. "Conducting Economic Evaluations Alongside Randomised Trials: Current Methodological Issues and Novel Approaches," PharmacoEconomics, Springer, vol. 34(5), pages 447-461, May.
    4. Hildegard Seidl & Matthias Hunger & Reiner Leidl & Christa Meisinger & Rupert Wende & Bernhard Kuch & Rolf Holle, 2015. "Cost-effectiveness of nurse-based case management versus usual care for elderly patients with myocardial infarction: results from the KORINNA study," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(6), pages 671-681, July.
    5. Jesse Elliott & Bláthnaid McCoy & Tammy Clifford & George A. Wells & Doug Coyle, 2018. "Economic Evaluation of Stiripentol for Dravet Syndrome: A Cost-Utility Analysis," PharmacoEconomics, Springer, vol. 36(10), pages 1253-1261, October.
    6. Saha, Sanjib & Gerdtham, Ulf-G. & Toresson, Håkan & Minthon, Lennart & Jarl, Johan, 2018. "Economic Evaluation of Interventions for Screening of Dementia," Working Papers 2018:20, Lund University, Department of Economics.
    7. Matthew Calver, 2016. "Measuring the Appropriate Outcomes for Better Decision-Making: A Framework to Guide the Analysis of Health Policy," CSLS Research Reports 2016-03, Centre for the Study of Living Standards.
    8. Luis Hernandez & Asli Ozen & Rodrigo DosSantos & Denis Getsios, 2016. "Systematic Review of Model-Based Economic Evaluations of Treatments for Alzheimer’s Disease," PharmacoEconomics, Springer, vol. 34(7), pages 681-707, July.
    9. Rosanna Tarricone & Giuditta Callea & Marko Ogorevc & Valentina Prevolnik Rupel, 2017. "Improving the Methods for the Economic Evaluation of Medical Devices," Health Economics, John Wiley & Sons, Ltd., vol. 26(S1), pages 70-92, February.
    10. Saha, Sanjib & Gerdtham, Ulf-G. & Toresson, Håkan & Minthon, Lennart & Jarl, Johan, 2018. "Economic Evaluation of Management of Dementia Patients - A Systematic Literature Review," Working Papers 2018:41, Lund University, Department of Economics.
    11. Axel C Mühlbacher & Andrew Sadler, 2021. "Comment on the paper "Cost-effectiveness of sofosbuvir in hepatitis C genotype 1 infection in Germany: A reanalysis of published results"," PLOS ONE, Public Library of Science, vol. 16(2), pages 1-4, February.
    12. Angela Devine & Alice Vahanian & Bernard Sawadogo & Souleymane Zan & Fadima Yaya Bocoum & Helen Kelly & Clare Gilham & Nicolas Nagot & Jason J Ong & Rosa Legood & Nicolas Meda & Alec Miners & Philippe, 2021. "Costs and cost-effectiveness of cervical cancer screening strategies in women living with HIV in Burkina Faso: The HPV in Africa Research Partnership (HARP) study," PLOS ONE, Public Library of Science, vol. 16(3), pages 1-16, March.
    13. Pieter T. Boer & Geert W. J. Frederix & Talitha L. Feenstra & Pepijn Vemer, 2016. "Unremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast Cancer," PharmacoEconomics, Springer, vol. 34(9), pages 833-845, September.
    14. Lisa Masucci & Jaclyn Beca & Mona Sabharwal & Jeffrey S. Hoch, 2017. "Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review (pCODR)," PharmacoEconomics - Open, Springer, vol. 1(4), pages 255-263, December.
    15. Christian Kromer & Daniel Celis & Diana Sonntag & Wiebke K Peitsch, 2018. "Biologicals and small molecules in psoriasis: A systematic review of economic evaluations," PLOS ONE, Public Library of Science, vol. 13(1), pages 1-22, January.
    16. Neill Booth & Pekka Rissanen & Teuvo L J Tammela & Paula Kujala & Ulf-Håkan Stenman & Kimmo Taari & Kirsi Talala & Anssi Auvinen, 2019. "Cost-effectiveness analysis of PSA-based mass screening: Evidence from a randomised controlled trial combined with register data," PLOS ONE, Public Library of Science, vol. 14(11), pages 1-17, November.
    17. Irma H J Everink & Jolanda C M van Haastregt & Silvia M A A Evers & Gertrudis I J M Kempen & Jos M G A Schols, 2018. "An economic evaluation of an integrated care pathway in geriatric rehabilitation for older patients with complex health problems," PLOS ONE, Public Library of Science, vol. 13(2), pages 1-21, February.
    18. Benjarin Santatiwongchai & Varit Chantarastapornchit & Thomas Wilkinson & Kittiphong Thiboonboon & Waranya Rattanavipapong & Damian G Walker & Kalipso Chalkidou & Yot Teerawattananon, 2015. "Methodological Variation in Economic Evaluations Conducted in Low- and Middle-Income Countries: Information for Reference Case Development," PLOS ONE, Public Library of Science, vol. 10(5), pages 1-15, May.
    19. Nadia YAKHELEF & Martine AUDIBERT & Bruno PEIRERA & Antoine MONS & Emmanuel CHABERT, 2015. "Cost-utility Analysis of Vertebroplasty versus Thoracolumbosacral Orthosis in the Treatment of Traumatic Vertebral Fractures," Working Papers 201534, CERDI.
    20. Mickaël Hiligsmann & Silvia Evers & Wafa Ben Sedrine & John Kanis & Bram Ramaekers & Jean-Yves Reginster & Stuart Silverman & Caroline Wyers & Annelies Boonen, 2015. "A Systematic Review of Cost-Effectiveness Analyses of Drugs for Postmenopausal Osteoporosis," PharmacoEconomics, Springer, vol. 33(3), pages 205-224, March.
    21. Shankar Prinja & Akashdeep Chauhan & Blake Angell & Indrani Gupta & Stephen Jan, 2015. "A Systematic Review of the State of Economic Evaluation for Health Care in India," Applied Health Economics and Health Policy, Springer, vol. 13(6), pages 595-613, December.
    22. Mbathio Dieng & Nikita Khanna & Nadine A. Kasparian & Daniel S. J. Costa & Phyllis N. Butow & Scott W. Menzies & Graham J. Mann & Anne E Cust & Rachael L. Morton, 2019. "Cost-Effectiveness of a Psycho-Educational Intervention Targeting Fear of Cancer Recurrence in People Treated for Early-Stage Melanoma," Applied Health Economics and Health Policy, Springer, vol. 17(5), pages 669-681, October.
    23. Fuxiao Li & Xiang Li & Chuanhai Guo & Ruiping Xu & Fenglei Li & Yaqi Pan & Mengfei Liu & Zhen Liu & Chao Shi & Hui Wang & Minmin Wang & Hongrui Tian & Fangfang Liu & Ying Liu & Jingjing Li & Hong Cai , 2019. "Estimation of Cost for Endoscopic Screening for Esophageal Cancer in a High-Risk Population in Rural China: Results from a Population-Level Randomized Controlled Trial," PharmacoEconomics, Springer, vol. 37(6), pages 819-827, June.
    24. Pepijn Vemer & Maureen Rutten-van Mölken, 2013. "The Road Not Taken: Transferability Issues in Multinational Trials," PharmacoEconomics, Springer, vol. 31(10), pages 863-876, October.
    25. James Buchanan & Sarah Wordsworth & Ruth Clifford & Pauline Robbe & Jenny C. Taylor & Anna Schuh & Samantha J. L. Knight, 2017. "Using Genomic Information to Guide Ibrutinib Treatment Decisions in Chronic Lymphocytic Leukaemia: A Cost-Effectiveness Analysis," PharmacoEconomics, Springer, vol. 35(8), pages 845-858, August.
    26. Clarke, Lorcan, 2020. "An introduction to economic studies, health emergencies, and COVID-19," LSE Research Online Documents on Economics 105051, London School of Economics and Political Science, LSE Library.
    27. Najmiatul Fitria & Antoinette D. I. Asselt & Maarten J. Postma, 2019. "Cost-effectiveness of controlling gestational diabetes mellitus: a systematic review," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(3), pages 407-417, April.
    28. Edward Burn & Alexander D. Liddle & Thomas W. Hamilton & Sunil Pai & Hemant G. Pandit & David W. Murray & Rafael Pinedo-Villanueva, 2017. "Choosing Between Unicompartmental and Total Knee Replacement: What Can Economic Evaluations Tell Us? A Systematic Review," PharmacoEconomics - Open, Springer, vol. 1(4), pages 241-253, December.
    29. Qi Cao & Erik Buskens & Hans L. Hillege & Tiny Jaarsma & Maarten Postma & Douwe Postmus, 2019. "Stratified treatment recommendation or one-size-fits-all? A health economic insight based on graphical exploration," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(3), pages 475-482, April.
    30. Thomas Grochtdreis & Hans-Helmut König & Alexander Dobruschkin & Gunhild von Amsberg & Judith Dams, 2018. "Cost-effectiveness analyses and cost analyses in castration-resistant prostate cancer: A systematic review," PLOS ONE, Public Library of Science, vol. 13(12), pages 1-25, December.
    31. Wendy Hens & Dirk Vissers & Nick Verhaeghe & Jan Gielen & Luc Van Gaal & Jan Taeymans, 2021. "Unsupervised Exercise Training Was Not Found to Improve the Metabolic Health or Phenotype over a 6-Month Dietary Intervention: A Randomised Controlled Trial with an Embedded Economic Analysis," IJERPH, MDPI, vol. 18(15), pages 1-13, July.
    32. Moallemi, Enayat A. & Elsawah, Sondoss & Ryan, Michael J., 2020. "Strengthening ‘good’ modelling practices in robust decision support: A reporting guideline for combining multiple model-based methods," Mathematics and Computers in Simulation (MATCOM), Elsevier, vol. 175(C), pages 3-24.
    33. Inigo Bermejo & Paul Tappenden & Ji-Hee Youn, 2017. "Replicating Health Economic Models: Firm Foundations or a House of Cards?," PharmacoEconomics, Springer, vol. 35(11), pages 1113-1121, November.
    34. Celene Y. L. Yap & Ya-seng (Arthur) Hsueh & Jonathan C. Knott & David McD Taylor & Esther W. Chan & David C. M. Kong, 2018. "Economic Evaluation of Midazolam–Droperidol Combination, Versus Droperidol or Olanzapine for the Management of Acute Agitation in the Emergency Department: A Within-Trial Analysis," PharmacoEconomics - Open, Springer, vol. 2(2), pages 141-151, June.
    35. Sarah J Stock & Margaret Horne & Merel Bruijn & Helen White & Kathleen A Boyd & Robert Heggie & Lisa Wotherspoon & Lorna Aucott & Rachel K Morris & Jon Dorling & Lesley Jackson & Manju Chandiramani & , 2021. "Development and validation of a risk prediction model of preterm birth for women with preterm labour symptoms (the QUIDS study): A prospective cohort study and individual participant data meta-analysi," PLOS Medicine, Public Library of Science, vol. 18(7), pages 1-22, July.
    36. Daisuke Goto & Ya-Chen Tina Shih & Pascal Lecomte & Melvin Olson & Chukwukadibia Udeze & Yujin Park & C. Daniel Mullins, 2017. "Regression-Based Approaches to Patient-Centered Cost-Effectiveness Analysis," PharmacoEconomics, Springer, vol. 35(7), pages 685-695, July.
    37. Yates, Brian T., 2021. "Toward collaborative cost-inclusive evaluation: Adaptations and transformations for evaluators and economists," Evaluation and Program Planning, Elsevier, vol. 89(C).
    38. Darcy M. Anderson & Ryan Cronk & Lucy Best & Mark Radin & Hayley Schram & J. Wren Tracy & Jamie Bartram, 2020. "Budgeting for Environmental Health Services in Healthcare Facilities: A Ten-Step Model for Planning and Costing," IJERPH, MDPI, vol. 17(6), pages 1-22, March.
    39. Carmen Selva-Sevilla & Elena Conde-Montero & Manuel Gerónimo-Pardo, 2020. "Bayesian Regression Model for a Cost-Utility and Cost-Effectiveness Analysis Comparing Punch Grafting Versus Usual Care for the Treatment of Chronic Wounds," IJERPH, MDPI, vol. 17(11), pages 1-21, May.
    40. Hoces de la Guardia, Fernando & Grant, Sean & Miguel, Edward, 2018. "A Framework for Open Policy Analysis," MetaArXiv jnyqh, Center for Open Science.
    41. Kamolpat Chaiyakittisopon & Oraluck Pattanaprateep & Narisa Ruenroengbun & Tunlanut Sapankaew & Atiporn Ingsathit & Gareth J. Mckay & John Attia & Ammarin Thakkinstian, 2021. "Evaluation of the cost-utility of phosphate binders as a treatment option for hyperphosphatemia in chronic kidney disease patients: a systematic review and meta-analysis of the economic evaluations," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(4), pages 571-584, June.
    42. Kim Edmunds & Penny Reeves & Paul Scuffham & Daniel A. Galvão & Robert U. Newton & Mark Jones & Nigel Spry & Dennis R. Taaffe & David Joseph & Suzanne K. Chambers & Haitham Tuffaha, 2020. "Cost-Effectiveness Analysis of Supervised Exercise Training in Men with Prostate Cancer Previously Treated with Radiation Therapy and Androgen-Deprivation Therapy," Applied Health Economics and Health Policy, Springer, vol. 18(5), pages 727-737, October.
    43. Stéphane Verguet & Jane J. Kim & Dean T. Jamison, 2016. "Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial," PharmacoEconomics, Springer, vol. 34(9), pages 913-923, September.
    44. Emma McManus & Tracey Sach, 2017. "Comment on “Replicating Health Economic Models: Firm Foundations or a House of Cards?”," PharmacoEconomics, Springer, vol. 35(11), pages 1187-1188, November.
    45. Melanie Runge & Magdalene Krensel & Claudia Westermann & Dominik Bindl & Klaus Nagels & Matthias Augustin & Albert Nienhaus, 2020. "Cost-Effectiveness Analysis of Direct-Acting Antiviral Agents for Occupational Hepatitis C Infections in Germany," IJERPH, MDPI, vol. 17(2), pages 1-16, January.
    46. Andrew Gawron & Dustin French & John Pandolfino & Colin Howden, 2014. "Economic Evaluations of Gastroesophageal Reflux Disease Medical Management," PharmacoEconomics, Springer, vol. 32(8), pages 745-758, August.
    47. Don Husereau & Michael Drummond & Stavros Petrou & Chris Carswell & David Moher & Dan Greenberg & Federico Augustovski & Andrew Briggs & Josephine Mauskopf & Elizabeth Loder, 2013. "Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement," PharmacoEconomics, Springer, vol. 31(5), pages 361-367, May.
    48. Praveen Thokala & Simon Dixon & Beate Jahn, 2015. "Resource Modelling: The Missing Piece of the HTA Jigsaw?," PharmacoEconomics, Springer, vol. 33(3), pages 193-203, March.
    49. Saha, Sanjib & Gerdtham, Ulf-G. & Toresson, Håkan & Minthon, Lennart & Jarl, Johan, 2018. "Economic Evaluation of Nonpharmacological Interventions for Dementia Patients and their Caregivers - A Systematic Literature Review," Working Papers 2018:10, Lund University, Department of Economics.
    50. Sabrina Storgaard Sørensen & Kjeld Møller Pedersen & Ulla Møller Weinreich & Lars Ehlers, 2017. "Economic Evaluation of Community-Based Case Management of Patients Suffering From Chronic Obstructive Pulmonary Disease," Applied Health Economics and Health Policy, Springer, vol. 15(3), pages 413-424, June.
    51. Andrés Pichon-Riviere & Demián Glujovsky & Osvaldo Ulises Garay & Federico Augustovski & Agustin Ciapponi & Magdalena Serpa & Fernando Althabe, 2015. "Oxytocin in Uniject Disposable Auto-Disable Injection System versus Standard Use for the Prevention of Postpartum Hemorrhage in Latin America and the Caribbean: A Cost-Effectiveness Analysis," PLOS ONE, Public Library of Science, vol. 10(6), pages 1-18, June.
    52. Chiranjeev Sanyal & Paul Stolee & Don Juzwishin & Don Husereau, 2018. "Economic evaluations of eHealth technologies: A systematic review," PLOS ONE, Public Library of Science, vol. 13(6), pages 1-11, June.
    53. David M Goodman & Rohit Ramaswamy & Marc Jeuland & Emmanuel K Srofenyoh & Cyril M Engmann & Adeyemi J Olufolabi & Medge D Owen, 2017. "The cost effectiveness of a quality improvement program to reduce maternal and fetal mortality in a regional referral hospital in Accra, Ghana," PLOS ONE, Public Library of Science, vol. 12(7), pages 1-19, July.
    54. Frank G. Sandmann & Julie V. Robotham & Sarah R. Deeny & W. John Edmunds & Mark Jit, 2018. "Estimating the opportunity costs of bed‐days," Health Economics, John Wiley & Sons, Ltd., vol. 27(3), pages 592-605, March.
    55. Jesse Elliott & Sasha Katwyk & Bláthnaid McCoy & Tammy Clifford & Beth K. Potter & Becky Skidmore & George A. Wells & Doug Coyle, 2019. "Decision Models for Assessing the Cost Effectiveness of Treatments for Pediatric Drug-Resistant Epilepsy: A Systematic Review of Economic Evaluations," PharmacoEconomics, Springer, vol. 37(10), pages 1261-1276, October.
    56. Wei Zhang & Aslam Anis, 2014. "Health-Related Productivity Loss: NICE to Recognize Soon, Good to Discuss Now," PharmacoEconomics, Springer, vol. 32(5), pages 425-427, May.
    57. João Pedro Steinhauser Motta & Ricardo E Steffen & Caroliny Samary Lobato & Vanessa Souza Mendonça & José Roberto Lapa e Silva, 2020. "Endobronchial ultrasound-guided transbronchial needle aspiration versus mediastinoscopy for mediastinal staging of lung cancer: A systematic review of economic evaluation studies," PLOS ONE, Public Library of Science, vol. 15(6), pages 1-15, June.
    58. Sanjib Saha & Birgitta Grahn & Ulf-G. Gerdtham & Kjerstin Stigmar & Sara Holmberg & Johan Jarl, 2019. "Structured physiotherapy including a work place intervention for patients with neck and/or back pain in primary care: an economic evaluation," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(2), pages 317-327, March.
    59. Yoko Laurence & Ulla Griffiths & Anna Vassall, 2015. "Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review," PharmacoEconomics, Springer, vol. 33(9), pages 939-955, September.
    60. Asrul Akmal Shafie & Chin Hui Ng & Yui Ping Tan & Nathorn Chaiyakunapruk, 2017. "Systematic Review of the Cost Effectiveness of Insulin Analogues in Type 1 and Type 2 Diabetes Mellitus," PharmacoEconomics, Springer, vol. 35(2), pages 141-162, February.
    61. Ahumada-Canale, Antonio & Vargas, Constanza & Martinez-Mardones, Francisco & Plaza-Plaza, José Cristian & Benrimoj, Shalom & Garcia-Cardenas, Victoria, 2021. "Cost-utility analysis of medication review with follow-up for cardiovascular outcomes: A microsimulation model," Health Policy, Elsevier, vol. 125(11), pages 1406-1414.
    62. Jacobs, Karel & Roman, Erin & Lambert, Jo & Moke, Lieven & Scheys, Lennart & Kesteloot, Katrien & Roodhooft, Filip & Cardoen, Brecht, 2022. "Variability drivers of treatment costs in hospitals: A systematic review," Health Policy, Elsevier, vol. 126(2), pages 75-86.
    63. Konstantin D Bergmeister & Luisa Große-Hartlage & Simeon C Daeschler & Patrick Rhodius & Arne Böcker & Marius Beyersdorff & Axel Olaf Kern & Ulrich Kneser & Leila Harhaus, 2020. "Acute and long-term costs of 268 peripheral nerve injuries in the upper extremity," PLOS ONE, Public Library of Science, vol. 15(4), pages 1-12, April.
    64. Habibollah Arefian & Monique Vogel & Anja Kwetkat & Michael Hartmann, 2016. "Economic Evaluation of Interventions for Prevention of Hospital Acquired Infections: A Systematic Review," PLOS ONE, Public Library of Science, vol. 11(1), pages 1-15, January.
    65. Brigid M Gillespie & Claudia Bull & Rachel Walker & Frances Lin & Shelley Roberts & Wendy Chaboyer, 2018. "Quality appraisal of clinical guidelines for surgical site infection prevention: A systematic review," PLOS ONE, Public Library of Science, vol. 13(9), pages 1-17, September.
    66. Stephanie Bogdewic & Rohit Ramaswamy & David M Goodman & Emmanuel K Srofenyoh & Sebnem Ucer & Medge D Owen, 2020. "The cost-effectiveness of a program to reduce intrapartum and neonatal mortality in a referral hospital in Ghana," PLOS ONE, Public Library of Science, vol. 15(11), pages 1-18, November.
    67. Franck Maunoury & Aurore Clément & Chizoba Nwankwo & Laurie Levy-Bachelot & Armand Abergel & Vincent Di Martino & Eric Thervet & Isabelle Durand-Zaleski, 2018. "Cost-effectiveness analysis of elbasvir-grazoprevir regimen for treating hepatitis C virus genotype 1 infection in stage 4-5 chronic kidney disease patients in France," PLOS ONE, Public Library of Science, vol. 13(3), pages 1-20, March.
    68. Magnus Zingmark & Fredrik Norström & Lars Lindholm & Synneve Dahlin-Ivanoff & Susanne Gustafsson, 2019. "Modelling long-term cost-effectiveness of health promotion for community-dwelling older people," European Journal of Ageing, Springer, vol. 16(4), pages 395-404, December.
    69. Qing Xia & Julie A. Campbell & Hasnat Ahmad & Barbara Graaff & Lei Si & Petr Otahal & Kevin Ratcliffe & Julie Turtle & John Marrone & Mohammed Huque & Barry Hagan & Matthew Green & Andrew J. Palmer, 2022. "Resource utilization and disaggregated cost analysis of bariatric surgery in the Australian public healthcare system," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(6), pages 941-952, August.
    70. Sabina Sanghera & Emma Frew & Janesh Gupta & Joe Kai & Tracy Roberts, 2015. "Exploring the Use of Cost-Benefit Analysis to Compare Pharmaceutical Treatments for Menorrhagia," PharmacoEconomics, Springer, vol. 33(9), pages 957-965, September.
    71. Mbathio Dieng & Robin M. Turner & Sarah J. Lord & Andrew J. Einstein & Alexander M. Menzies & Robyn P. M. Saw & Omgo E. Nieweg & John F. Thompson & Rachael L. Morton, 2022. "Cost-Effectiveness of PET/CT Surveillance Schedules to Detect Distant Recurrence of Resected Stage III Melanoma," IJERPH, MDPI, vol. 19(4), pages 1-13, February.
    72. Cochrane, M. & Watson, P.M. & Timpson, H. & Haycox, A. & Collins, B. & Jones, L. & Martin, A. & Graves, L.E.F., 2019. "Systematic review of the methods used in economic evaluations of targeted physical activity and sedentary behaviour interventions," Social Science & Medicine, Elsevier, vol. 232(C), pages 156-167.
    73. Katherine Edwards & Natasha Jones & Julia Newton & Charlie Foster & Andrew Judge & Kate Jackson & Nigel K. Arden & Rafael Pinedo-Villanueva, 2017. "The cost-effectiveness of exercise-based cardiac rehabilitation: a systematic review of the characteristics and methodological quality of published literature," Health Economics Review, Springer, vol. 7(1), pages 1-23, December.
    74. Simon Deeming & Kim Edmunds & Alice Knight & Andrew Searles & Anthony P. Shakeshaft & Christopher M. Doran, 2022. "A Benefit-Cost Analysis of BackTrack, a Multi-Component, Community-Based Intervention for High-Risk Young People in a Rural Australian Setting," IJERPH, MDPI, vol. 19(16), pages 1-12, August.
    75. Gillian R. Currie & Raymond Lee & Luz Palacios-Derflingher & Brent Hagel & Amanda M. Black & Shelina Babul & Martin Mrazik & Deborah A. Marshall & Carolyn A. Emery, 2021. "Reality Check 2: The Cost-Effectiveness of Policy Disallowing Body Checking in Non-Elite 13- to 14-Year-Old Ice Hockey Players," IJERPH, MDPI, vol. 18(12), pages 1-10, June.
    76. Louisa G. Gordon & William Leung & Richard Johns & Bronwen McNoe & Daniel Lindsay & Katharina M. D. Merollini & Thomas M. Elliott & Rachel E. Neale & Catherine M. Olsen & Nirmala Pandeya & David C. Wh, 2022. "Estimated Healthcare Costs of Melanoma and Keratinocyte Skin Cancers in Australia and Aotearoa New Zealand in 2021," IJERPH, MDPI, vol. 19(6), pages 1-14, March.
    77. Don Husereau & Michael Drummond & Stavros Petrou & Dan Greenberg & Josephine Mauskopf & Federico Augustovski & Andrew Briggs & David Moher & Elizabeth Loder & Chris Carswell, 2015. "Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration," PharmacoEconomics, Springer, vol. 33(5), pages 535-536, May.
    78. Nina van der Vliet & Anita W.M. Suijkerbuijk & Adriana T. de Blaeij & G. Ardine de Wit & Paul F. van Gils & Brigit A.M. Staatsen & Rob Maas & Johan J. Polder, 2020. "Ranking Preventive Interventions from Different Policy Domains: What Are the Most Cost-Effective Ways to Improve Public Health?," IJERPH, MDPI, vol. 17(6), pages 1-24, March.
    79. Saara Huoponen & Marja Blom, 2015. "A Systematic Review of the Cost-Effectiveness of Biologics for the Treatment of Inflammatory Bowel Diseases," PLOS ONE, Public Library of Science, vol. 10(12), pages 1-23, December.
    80. Sergio Iannazzo & Ange-Christelle Iliza & Louise Perrault, 2018. "Disease-Modifying Therapies for Multiple Sclerosis: A Systematic Literature Review of Cost-Effectiveness Studies," PharmacoEconomics, Springer, vol. 36(2), pages 189-204, February.
    81. Wen Wan & M. Reza Skandari & Alexa Minc & Aviva G. Nathan & Parmida Zarei & Aaron N. Winn & Michael O’Grady & Elbert S. Huang, 2018. "Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial," Medical Decision Making, , vol. 38(8), pages 942-953, November.
    82. Sarah J Iribarren & Kenrick Cato & Louise Falzon & Patricia W Stone, 2017. "What is the economic evidence for mHealth? A systematic review of economic evaluations of mHealth solutions," PLOS ONE, Public Library of Science, vol. 12(2), pages 1-20, February.
    83. Carlos K. H. Wong & Brian H. H. Lang & Vivian Y. W. Guo & Cindy L. K. Lam, 2016. "Possible Impact of Incremental Cost-Effectiveness Ratio (ICER) on Decision Making for Cancer Screening in Hong Kong: A Systematic Review," Applied Health Economics and Health Policy, Springer, vol. 14(6), pages 647-657, December.
    84. Nadia Yakhelef & Martine Audibert & Gabriella Ferlazzo & Joseph Sitienei & Steve Wanjala & Francis Varaine & Maryline Bonnet & Helena Huerga, 2020. "Cost-effectiveness of diagnostic algorithms including lateral-flow urine lipoarabinomannan for HIV-positive patients with symptoms of tuberculosis," PLOS ONE, Public Library of Science, vol. 15(1), pages 1-17, January.
    85. Simon van der Schans & Lucas M. A. Goossens & Melinde R. S. Boland & Janwillem W. H. Kocks & Maarten J. Postma & Job F. M. van Boven & Maureen P. M. H. Rutten-van Mölken, 2017. "Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and Recommendatio," PharmacoEconomics, Springer, vol. 35(1), pages 43-63, January.
    86. Syed Mohiuddin, 2014. "A Systematic and Critical Review of Model-Based Economic Evaluations of Pharmacotherapeutics in Patients with Bipolar Disorder," Applied Health Economics and Health Policy, Springer, vol. 12(4), pages 359-372, August.
    87. Natasha Howard & Lorna Guinness & Mark Rowland & Naeem Durrani & Kristian S Hansen, 2017. "Cost-effectiveness of adding indoor residual spraying to case management in Afghan refugee settlements in Northwest Pakistan during a prolonged malaria epidemic," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 11(10), pages 1-18, October.
    88. Andrew Briggs & Rachel Nugent, 2016. "Editorial," Health Economics, John Wiley & Sons, Ltd., vol. 25(S1), pages 6-8, February.
    89. Don Husereau & Michael Drummond & Federico Augustovski & Esther Bekker-Grob & Andrew H. Briggs & Chris Carswell & Lisa Caulley & Nathorn Chaiyakunapruk & Dan Greenberg & Elizabeth Loder & Josephine Ma, 2022. "Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations," Applied Health Economics and Health Policy, Springer, vol. 20(2), pages 213-221, March.
    90. Beena Joshi & Kusum V. Moray & Oshima Sachin & Himanshu Chaurasia & Shahina Begum, 2021. "Cost Effectiveness of Introducing Etonorgestrel Contraceptive Implant into India’s Current Family Welfare Programme," Applied Health Economics and Health Policy, Springer, vol. 19(2), pages 267-277, March.
    91. Ben F M Wijnen & Karin Pos & Eva Velthorst & Frederike Schirmbeck & Hoi Yau Chan & Lieuwe de Haan & Mark van der Gaag & Silvia M A A Evers & Filip Smit, 2018. "Economic evaluation of brief cognitive behavioural therapy for social activation in recent-onset psychosis," PLOS ONE, Public Library of Science, vol. 13(11), pages 1-16, November.
    92. Neily Zakiyah & Antoinette D I van Asselt & Frank Roijmans & Maarten J Postma, 2016. "Economic Evaluation of Family Planning Interventions in Low and Middle Income Countries; A Systematic Review," PLOS ONE, Public Library of Science, vol. 11(12), pages 1-19, December.
    93. Feng Xie & A. Pickard & Paul Krabbe & Dennis Revicki & Rosalie Viney & Nancy Devlin & David Feeny, 2015. "A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE)," PharmacoEconomics, Springer, vol. 33(8), pages 867-877, August.
    94. Deidda, Manuela & Geue, Claudia & Kreif, Noemi & Dundas, Ruth & McIntosh, Emma, 2019. "A framework for conducting economic evaluations alongside natural experiments," Social Science & Medicine, Elsevier, vol. 220(C), pages 353-361.
    95. Boshen Jiao & Anirban Basu & Joshua Roth & M. Bender & Ilsa Rovira & Traci Clemons & Dalyna Quach & Scott Ramsey & Beth Devine, 2021. "The Use of Cost-Effectiveness Analysis in Sickle Cell Disease: A Critical Review of the Literature," PharmacoEconomics, Springer, vol. 39(11), pages 1225-1241, November.
    96. Emma McManus & David Turner & Tracey Sach, 2019. "Can You Repeat That? Exploring the Definition of a Successful Model Replication in Health Economics," PharmacoEconomics, Springer, vol. 37(11), pages 1371-1381, November.
    97. Jagpreet Chhatwal & Tianhua He & Maria A. Lopez-Olivo, 2016. "Systematic Review of Modelling Approaches for the Cost Effectiveness of Hepatitis C Treatment with Direct-Acting Antivirals," PharmacoEconomics, Springer, vol. 34(6), pages 551-567, June.
    98. Jonathan Karnon, 2016. "Model Validation: Has it’s Time Come?," PharmacoEconomics, Springer, vol. 34(9), pages 829-831, September.
    99. Lisanne I. Lier & Judith E. Bosmans & Hein P. J. Hout & Lidwine B. Mokkink & Wilbert B. Hout & G. Ardine Wit & Carmen D. Dirksen & Henk L. G. R. Nies & Cees M. P. M. Hertogh & Henriëtte G. Roest, 2018. "Consensus-based cross-European recommendations for the identification, measurement and valuation of costs in health economic evaluations: a European Delphi study," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(7), pages 993-1008, September.
    100. Kathryn Schnippel & Naomi Lince-Deroche & Theo van den Handel & Seithati Molefi & Suann Bruce & Cynthia Firnhaber, 2015. "Cost Evaluation of Reproductive and Primary Health Care Mobile Service Delivery for Women in Two Rural Districts in South Africa," PLOS ONE, Public Library of Science, vol. 10(3), pages 1-13, March.
    101. Gabriela B Gomez & Nicola Foster & Daniella Brals & Heleen E Nelissen & Oladimeji A Bolarinwa & Marleen E Hendriks & Alexander C Boers & Diederik van Eck & Nicole Rosendaal & Peju Adenusi & Kayode Agb, 2015. "Improving Maternal Care through a State-Wide Health Insurance Program: A Cost and Cost-Effectiveness Study in Rural Nigeria," PLOS ONE, Public Library of Science, vol. 10(9), pages 1-17, September.
    102. Natasha Brusco & Andrea Voogt & Melissa Nott & Libby Callaway & Mae Mansoubi & Natasha Layton, 2022. "Meeting Unmet Needs for Stroke Rehabilitation in Rural Public Health: Explorative Economic Evaluation of Upper Limb Robotics-Based Technologies through a Capabilities Lens," Societies, MDPI, vol. 12(5), pages 1-20, October.
    103. Stephen Mac & Sara R da Silva & Beate Sander, 2019. "The economic burden of Lyme disease and the cost-effectiveness of Lyme disease interventions: A scoping review," PLOS ONE, Public Library of Science, vol. 14(1), pages 1-17, January.
    104. Png, May Ee & Yang, Miaoqing & Taylor-Phillips, Sian & Ratushnyak, Svetlana & Roberts, Nia & White, Ashley & Hinton, Lisa & Boardman, Felicity & McNiven, Abigail & Fisher, Jane & Thilaganathan, Baskar, 2022. "Benefits and harms adopted by health economic assessments evaluating antenatal and newborn screening programmes in OECD countries: A systematic review of 336 articles and reports," Social Science & Medicine, Elsevier, vol. 314(C).
    105. Andrea Iannaccone & Thomas Marwick, 2015. "Cost Effectiveness of Transcatheter Aortic Valve Replacement Compared with Medical Management or Surgery for Patients with Aortic Stenosis," Applied Health Economics and Health Policy, Springer, vol. 13(1), pages 29-45, February.
    106. Rachel Elliott & Koen Putman & James Davies & Lieven Annemans, 2014. "A Review of the Methodological Challenges in Assessing the Cost Effectiveness of Pharmacist Interventions," PharmacoEconomics, Springer, vol. 32(12), pages 1185-1199, December.
    107. Rod S. Taylor & Anthony Bentley & Kaylie Metcalfe & Melvin D. Lobo & Ajay J. Kirtane & Michel Azizi & Christopher Clark & Kieran Murphy & Jennifer H. Boer & Marjolijn Keep & An Thu Ta & Neil C. Barman, 2024. "Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension," PharmacoEconomics - Open, Springer, vol. 8(4), pages 525-537, July.
    108. Wolf Rogowski & Wolfram Elsner, 2021. "How economics can help mitigate climate change - a critical review and conceptual analysis of economic paradigms," Bremen Papers on Economics & Innovation 2106, University of Bremen, Faculty of Business Studies and Economics.
    109. Abualbishr Alshreef & Michelle Jenks & William Green & Simon Dixon, 2016. "Review of Economic Submissions to NICE Medical Technologies Evaluation Programme," Applied Health Economics and Health Policy, Springer, vol. 14(6), pages 623-634, December.
    110. Ali Hajjar & Mehmet A Ergun & Oguzhan Alagoz & Murtuza Rampurwala, 2019. "Cost-effectiveness of adjuvant paclitaxel and trastuzumab for early-stage node-negative, HER2-positive breast cancer," PLOS ONE, Public Library of Science, vol. 14(6), pages 1-14, June.
    111. Paul R Bessell & Crispin Lumbala & Pascal Lutumba & Sylvain Baloji & Sylvain Biéler & Joseph M Ndung'u, 2018. "Cost-effectiveness of using a rapid diagnostic test to screen for human African trypanosomiasis in the Democratic Republic of the Congo," PLOS ONE, Public Library of Science, vol. 13(9), pages 1-18, September.
    112. Matteo Ruggeri & Chiara Cadeddu & Paolo Roazzi & Donatella Mandolini & Mauro Grigioni & Marco Marchetti, 2020. "Multi–Criteria–Decision–Analysis (MCDA) for the Horizon Scanning of Health Innovations an Application to COVID 19 Emergency," IJERPH, MDPI, vol. 17(21), pages 1-9, October.
    113. Huajie Jin & Paul McCrone & James H. MacCabe, 2019. "Stratified medicine in schizophrenia: how accurate would a test of drug response need to be to achieve cost-effective improvements in quality of life?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(9), pages 1425-1435, December.
    114. Candio, Paolo & Meads, David & Hill, Andrew J. & Bojke, Laura, 2020. "Modelling the impact of physical activity on public health: A review and critique," Health Policy, Elsevier, vol. 124(10), pages 1155-1164.
    115. Yue Yin & Yusi Tu & Mingye Zhao & Wenxi Tang, 2022. "Effectiveness and Cost-Effectiveness of Non-Pharmacological Interventions among Chinese Adults with Prediabetes: A Protocol for Network Meta-Analysis and CHIME-Modeled Cost-Effectiveness Analysis," IJERPH, MDPI, vol. 19(3), pages 1-12, January.
    116. Luana Nice da Silva Oliveira & Alexander Itria & Erika Coutinho Lima, 2019. "Cost of illness and program of dengue: A systematic review," PLOS ONE, Public Library of Science, vol. 14(2), pages 1-15, February.
    117. Stephen E Congly & Abdel Aziz Shaheen & Mark G Swain, 2021. "Modelling the cost effectiveness of non-alcoholic fatty liver disease risk stratification strategies in the community setting," PLOS ONE, Public Library of Science, vol. 16(5), pages 1-14, May.
    118. David Brain & Amarzaya Jadambaa, 2021. "Economic Evaluation of Long-Term Survivorship Care for Cancer Patients in OECD Countries: A Systematic Review for Decision-Makers," IJERPH, MDPI, vol. 18(21), pages 1-34, November.
    119. Ana Teresa Paquete & Luís Silva Miguel & Ursula Becker & Catarina Pereira & Carlos Gouveia Pinto, 2017. "Cost‐Effectiveness Analysis of Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukaemia in Portuguese Patients who are Unsuitable for Full-Dose Fludarabine-Based Therapy," Applied Health Economics and Health Policy, Springer, vol. 15(4), pages 501-512, August.
    120. Brown, Vicki & Diomedi, Belen Zapata & Moodie, Marj & Veerman, J. Lennert & Carter, Rob, 2016. "A systematic review of economic analyses of active transport interventions that include physical activity benefits," Transport Policy, Elsevier, vol. 45(C), pages 190-208.
    121. Zartashia Ghani & Johan Jarl & Johan Sanmartin Berglund & Martin Andersson & Peter Anderberg, 2020. "The Cost-Effectiveness of Mobile Health (mHealth) Interventions for Older Adults: Systematic Review," IJERPH, MDPI, vol. 17(15), pages 1-13, July.
    122. Rachel Elliott & Koen Putman & Matthew Franklin & Lieven Annemans & Nick Verhaeghe & Martin Eden & Jasdeep Hayre & Sarah Rodgers & Aziz Sheikh & Anthony Avery, 2014. "Cost Effectiveness of a Pharmacist-Led Information Technology Intervention for Reducing Rates of Clinically Important Errors in Medicines Management in General Practices (PINCER)," PharmacoEconomics, Springer, vol. 32(6), pages 573-590, June.
    123. Roberta Ara & Tessa Peasgood & Clara Mukuria & Helene Chevrou-Severac & Donna Rowen & Ismail Azzabi-Zouraq & Suzy Paisley & Tracey Young & Ben Hout & John Brazier, 2017. "Sourcing and Using Appropriate Health State Utility Values in Economic Models in Health Care," PharmacoEconomics, Springer, vol. 35(1), pages 7-9, December.
    124. Xinyang Hua & Thomas Wai-Chun Lung & Andrew Palmer & Lei Si & William H. Herman & Philip Clarke, 2017. "How Consistent is the Relationship between Improved Glucose Control and Modelled Health Outcomes for People with Type 2 Diabetes Mellitus? a Systematic Review," PharmacoEconomics, Springer, vol. 35(3), pages 319-329, March.
    125. Marcus Sellars & Josephine M Clayton & Karen M Detering & Allison Tong & David Power & Rachael L Morton, 2019. "Costs and outcomes of advance care planning and end-of-life care for older adults with end-stage kidney disease: A person-centred decision analysis," PLOS ONE, Public Library of Science, vol. 14(5), pages 1-11, May.
    126. Paul Tappenden & James Chilcott, 2014. "Avoiding and Identifying Errors and Other Threats to the Credibility of Health Economic Models," PharmacoEconomics, Springer, vol. 32(10), pages 967-979, October.
    127. Huajie Jin & Paul Tappenden & Stewart Robinson & Evanthia Achilla & David Aceituno & Sarah Byford, 2020. "Systematic review of the methods of health economic models assessing antipsychotic medication for schizophrenia," PLOS ONE, Public Library of Science, vol. 15(7), pages 1-18, July.
    128. Manuel B Huber & Margarethe E Wacker & Claus F Vogelmeier & Reiner Leidl, 2015. "Excess Costs of Comorbidities in Chronic Obstructive Pulmonary Disease: A Systematic Review," PLOS ONE, Public Library of Science, vol. 10(4), pages 1-17, April.
    129. Holger Möller & Fiona Haigh & Rema Hayek & Lennert Veerman, 2020. "What Is the Best Practice Method for Quantifying the Health and Economic Benefits of Active Transport?," IJERPH, MDPI, vol. 17(17), pages 1-16, August.
    130. Elizabeth Parody-Rúa & Maria Rubio-Valera & César Guevara-Cuellar & Ainhoa Gómez-Lumbreras & Marc Casajuana-Closas & Cristina Carbonell-Duacastella & Ignacio Aznar-Lou, 2020. "Economic Evaluations Informed Exclusively by Real World Data: A Systematic Review," IJERPH, MDPI, vol. 17(4), pages 1-18, February.
    131. Nadia Yakhelef & Martine Audibert & Bruno Peirera & Antoine Mons & Emmanuel Chabert, 2015. "Cost-utility Analysis of Vertebroplasty versus Thoracolumbosacral Orthosis in the Treatment of Traumatic Vertebral Fractures," Working Papers halshs-01241824, HAL.
    132. S. Rajsic & H. Gothe & H. H. Borba & G. Sroczynski & J. Vujicic & T. Toell & Uwe Siebert, 2019. "Economic burden of stroke: a systematic review on post-stroke care," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(1), pages 107-134, February.
    133. Annabel Sandra Mueller-Stierlin & Uemmueguelsuem Dinc & Katrin Herder & Julia Walendzik & Matthias Schuetzwohl & Thomas Becker & Reinhold Kilian, 2022. "The Cost-Effectiveness Analysis of an Integrated Mental Health Care Programme in Germany," IJERPH, MDPI, vol. 19(11), pages 1-14, June.
    134. Jonathon Campbell & Thenuga Sasitharan & Fawziah Marra, 2015. "A Systematic Review of Studies Evaluating the Cost Utility of Screening High-Risk Populations for Latent Tuberculosis Infection," Applied Health Economics and Health Policy, Springer, vol. 13(4), pages 325-340, August.
    135. Michelle Blumfield & Carlene Starck & Tim Keighley & Peter Petocz & Anna Roesler & Kylie Abbott & Tim Cassettari & Skye Marshall & Flavia Fayet-Moore, 2021. "Diet and Economic Modelling to Improve the Quality and Affordability of the Australian Diet for Low and Medium Socioeconomic Households," IJERPH, MDPI, vol. 18(11), pages 1-18, May.
    136. Mutsa Gumbie & Bonny Parkinson & Henry Cutler & Natalie Gauld & Virginia Mumford, 2019. "Is Reclassification of the Oral Contraceptive Pill from Prescription to Pharmacist-Only Cost Effective? Application of an Economic Evaluation Approach to Regulatory Decisions," PharmacoEconomics, Springer, vol. 37(8), pages 1049-1064, August.
    137. Ana C. Montesinos Gálvez & Francisco Jódar Sánchez & Carmen Alcántara Moreno & Antonio J. Pérez Fernández & Rosario Benítez García & Mercedes Coca López & María Paz Bienvenido Ramírez & Monserrat Cabr, 2020. "Value-Based Healthcare in Ostomies," IJERPH, MDPI, vol. 17(16), pages 1-15, August.
    138. Ferrari, Giulia & Torres-Rueda, Sergio & Michaels-Igbokwe, Christine & Watts, Charlotte & Jewkes, Rachel & Vassall, Anna, 2019. "Economic evaluation of public health interventions: an application to interventions for the prevention of violence against women and girls implemented by the “what works to prevent violence against wo," LSE Research Online Documents on Economics 103639, London School of Economics and Political Science, LSE Library.
    139. Oliver Lange & Julian Plath & Timo F. Dziggel & David F. Karpa & Mattis Keil & Tom Becker & Wolf H. Rogowski, 2022. "A Transparency Checklist for Carbon Footprint Calculations Applied within a Systematic Review of Virtual Care Interventions," IJERPH, MDPI, vol. 19(12), pages 1-14, June.
    140. Finkelstein, Eric A. & Bilger, Marcel & Baid, Drishti, 2019. "Effectiveness and cost-effectiveness of incentives as a tool for prevention of non-communicable diseases: A systematic review," Social Science & Medicine, Elsevier, vol. 232(C), pages 340-350.
    141. B Ekman & H Nero & L S Lohmander & L E Dahlberg, 2020. "Costing analysis of a digital first-line treatment platform for patients with knee and hip osteoarthritis in Sweden," PLOS ONE, Public Library of Science, vol. 15(8), pages 1-12, August.
    142. Michelle M.A. Kip & Maarten J. IJzerman & Martin Henriksson & Tracy Merlin & Milton C. Weinstein & Charles E. Phelps & Ron Kusters & Hendrik Koffijberg, 2018. "Toward Alignment in the Reporting of Economic Evaluations of Diagnostic Tests and Biomarkers: The AGREEDT Checklist," Medical Decision Making, , vol. 38(7), pages 778-788, October.
    143. Jain, Vageesh & Crosby, Liam & Baker, Peter & Chalkidou, Kalipso, 2020. "Distributional equity as a consideration in economic and modelling evaluations of health taxes: A systematic review," Health Policy, Elsevier, vol. 124(9), pages 919-931.
    144. P. Vemer & I. Corro Ramos & G. A. K. Voorn & M. J. Al & T. L. Feenstra, 2016. "AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users," PharmacoEconomics, Springer, vol. 34(4), pages 349-361, April.
    145. Anita W M Suijkerbuijk & Albert Jan van Hoek & Jelle Koopsen & Robert A de Man & Marie-Josee J Mangen & Hester E de Melker & Johan J Polder & G Ardine de Wit & Irene K Veldhuijzen, 2018. "Cost-effectiveness of screening for chronic hepatitis B and C among migrant populations in a low endemic country," PLOS ONE, Public Library of Science, vol. 13(11), pages 1-16, November.
    146. Maximilian Hatz & Reiner Leidl & Nichola Yates & Björn Stollenwerk, 2014. "A Systematic Review of the Quality of Economic Models Comparing Thrombosis Inhibitors in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention," PharmacoEconomics, Springer, vol. 32(4), pages 377-393, April.
    147. Stuart Wright & Cheryl Jones & Katherine Payne & Nimarta Dharni & Fiona Ulph, 2015. "The Role of Information Provision in Economic Evaluations of Newborn Bloodspot Screening: A Systematic Review," Applied Health Economics and Health Policy, Springer, vol. 13(6), pages 615-626, December.
    148. Larjow, Eugenia, 2018. "Administrative costs in health care—A scoping review," Health Policy, Elsevier, vol. 122(11), pages 1240-1248.
    149. Fattore, Giovanni & Federici, Carlo & Drummond, Michael & Mazzocchi, Mario & Detzel, Patrick & Hutton, Zsuzsa V & Shankar, Bhavani, 2021. "Economic evaluation of nutrition interventions: Does one size fit all?," Health Policy, Elsevier, vol. 125(9), pages 1238-1246.
    150. Stephanie Nicolian & Thibault Butel & Laetitia Gambotti & Manon Durand & Antoine Filipovic-Pierucci & Alain Mallet & Mamadou Kone & Isabelle Durand-Zaleski & Marc Dommergues, 2019. "Cost-effectiveness of acupuncture versus standard care for pelvic and low back pain in pregnancy: A randomized controlled trial," PLOS ONE, Public Library of Science, vol. 14(4), pages 1-16, April.
    151. Emilie Baro & Tatiana Galperine & Fanette Denies & Damien Lannoy & Xavier Lenne & Pascal Odou & Benoit Guery & Benoit Dervaux, 2017. "Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in France," PLOS ONE, Public Library of Science, vol. 12(1), pages 1-15, January.
    152. R. Brett McQueen & Danielle N. Sheehan & Melanie D. Whittington & Job F. M. Boven & Jonathan D. Campbell, 2018. "Cost-Effectiveness of Biological Asthma Treatments: A Systematic Review and Recommendations for Future Economic Evaluations," PharmacoEconomics, Springer, vol. 36(8), pages 957-971, August.
    153. Jason Madan & Meghan Bruce Kumar & Miriam Taegtmeyer & Edwine Barasa & Swaran Preet Singh, 2020. "SEEP-CI: A Structured Economic Evaluation Process for Complex Health System Interventions," IJERPH, MDPI, vol. 17(18), pages 1-12, September.
    154. Jesse Elliott & Bláthnaid McCoy & Tammy Clifford & Beth K. Potter & George A. Wells & Doug Coyle, 2020. "Economic Evaluation of Cannabinoid Oil for Dravet Syndrome: A Cost-Utility Analysis," PharmacoEconomics, Springer, vol. 38(9), pages 971-980, September.
    155. Verin Lertjanyakun & Nathorn Chaiyakunapruk & Susumu Kunisawa & Yuichi Imanaka, 2018. "Cost-Effectiveness of Second-Line Endocrine Therapies in Postmenopausal Women with Hormone Receptor–positive and Human Epidermal Growth Factor Receptor 2–negative Metastatic Breast Cancer in Japan," PharmacoEconomics, Springer, vol. 36(9), pages 1113-1124, September.
    156. Emma Beard & Robert West & Fabiana Lorencatto & Ben Gardner & Susan Michie & Lesley Owens & Lion Shahab, 2019. "What do cost-effective health behaviour-change interventions contain? A comparison of six domains," PLOS ONE, Public Library of Science, vol. 14(4), pages 1-24, April.
    157. Patrick Zueger & Neil Schultz & Todd Lee, 2014. "Cost Effectiveness of Liraglutide in Type II Diabetes: A Systematic Review," PharmacoEconomics, Springer, vol. 32(11), pages 1079-1091, November.
    158. Tom L. Drake & Angela Devine & Shunmay Yeung & Nicholas P. J. Day & Lisa J. White & Yoel Lubell, 2016. "Dynamic Transmission Economic Evaluation of Infectious Disease Interventions in Low‐ and Middle‐Income Countries: A Systematic Literature Review," Health Economics, John Wiley & Sons, Ltd., vol. 25(S1), pages 124-139, February.
    159. Kathryn Schnippel & Cynthia Firnhaber & Francesca Conradie & Norbert Ndjeka & Edina Sinanovic, 2018. "Incremental Cost Effectiveness of Bedaquiline for the Treatment of Rifampicin-Resistant Tuberculosis in South Africa: Model-Based Analysis," Applied Health Economics and Health Policy, Springer, vol. 16(1), pages 43-54, February.
    160. Valentin Brodszky & Zsuzsanna Beretzky & Petra Baji & Fanni Rencz & Márta Péntek & Alexandru Rotar & Konstantin Tachkov & Susanne Mayer & Judit Simon & Maciej Niewada & Rok Hren & László Gulácsi, 2019. "Cost-of-illness studies in nine Central and Eastern European countries," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(1), pages 155-172, June.
    161. Haru Iino & Masayuki Hashiguchi & Satoko Hori, 2022. "Estimating the range of incremental cost-effectiveness thresholds for healthcare based on willingness to pay and GDP per capita: A systematic review," PLOS ONE, Public Library of Science, vol. 17(4), pages 1-17, April.
    162. Louisa G. Gordon & Elizabeth G. Eakin & Rosalind R. Spence & Christopher Pyke & John Bashford & Christobel Saunders & Sandra C. Hayes, 2020. "Cost-Effectiveness Analysis from a Randomized Controlled Trial of Tailored Exercise Prescription for Women with Breast Cancer with 8-Year Follow-Up," IJERPH, MDPI, vol. 17(22), pages 1-13, November.
    163. Elizabeth A. Geelhoed & David E. Bloom & Catherine Bock & Paul Flatau & Joelie Mandzufas & Ian Li & Donna Cross, 2022. "Informing Resource Allocation for Investment in Early Childhood: A Review of the International Peer‐Reviewed Evidence," Australian Economic Review, The University of Melbourne, Melbourne Institute of Applied Economic and Social Research, vol. 55(2), pages 215-231, June.
    164. David Brain & Jonathan Mitchell & James O’Beirne, 2020. "Cost-effectiveness analysis of an outreach model of Hepatitis C Virus (HCV) assessment to facilitate HCV treatment in primary care," PLOS ONE, Public Library of Science, vol. 15(6), pages 1-13, June.
    165. Christopher Wai Hung Yau & Erik Lenguerrand & Steve Morris & Tim Draycott & Elena Pizzo, 2021. "A model-based cost-utility analysis of multi-professional simulation training in obstetric emergencies," PLOS ONE, Public Library of Science, vol. 16(3), pages 1-18, March.
    166. Huong Ngoc Quynh Tran & Emma McMahon & Marj Moodie & Jaithri Ananthapavan, 2021. "A Systematic Review of Economic Evaluations of Health-Promoting Food Retail-Based Interventions," IJERPH, MDPI, vol. 18(3), pages 1-20, February.
    167. Gregory Merlo & Katie Page & Julie Ratcliffe & Kate Halton & Nicholas Graves, 2015. "Bridging the Gap: Exploring the Barriers to Using Economic Evidence in Healthcare Decision Making and Strategies for Improving Uptake," Applied Health Economics and Health Policy, Springer, vol. 13(3), pages 303-309, June.
    168. Michael J. Zoratti & A. Simon Pickard & Peep F. M. Stalmeier & Daniel Ollendorf & Andrew Lloyd & Kelvin K W Chan & Don Husereau & John E. Brazier & Murray Krahn & Mitchell Levine & Lehana Thabane & Fe, 2021. "Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(5), pages 723-733, July.
    169. Melina Dritsaki & Felix Achana & James Mason & Stavros Petrou, 2017. "Methodological Issues Surrounding the Use of Baseline Health-Related Quality of Life Data to Inform Trial-Based Economic Evaluations of Interventions Within Emergency and Critical Care Settings: A Sys," PharmacoEconomics, Springer, vol. 35(5), pages 501-515, May.
    170. Alyson Mahar & Abraham El-Sedfy & Savtaj Brar & Ana Johnson & Natalie Coburn, 2015. "Are We Lacking Economic Evaluations in Gastric Cancer Treatment?," PharmacoEconomics, Springer, vol. 33(2), pages 83-87, February.
    171. Freekje van Asten & Charlotte T J Michels & Carel B Hoyng & Gert Jan van der Wilt & B Jeroen Klevering & Maroeska M Rovers & Janneke P C Grutters, 2018. "The cost-effectiveness of bevacizumab, ranibizumab and aflibercept for the treatment of age-related macular degeneration—A cost-effectiveness analysis from a societal perspective," PLOS ONE, Public Library of Science, vol. 13(5), pages 1-14, May.
    172. Darcy M. Anderson & Ryan Cronk & Donald Fejfar & Emily Pak & Michelle Cawley & Jamie Bartram, 2021. "Safe Healthcare Facilities: A Systematic Review on the Costs of Establishing and Maintaining Environmental Health in Facilities in Low- and Middle-Income Countries," IJERPH, MDPI, vol. 18(2), pages 1-22, January.
    173. Elisabet Jacobsen & Dwayne Boyers & Alison Avenell, 2020. "Challenges of Systematic Reviews of Economic Evaluations: A Review of Recent Reviews and an Obesity Case Study," PharmacoEconomics, Springer, vol. 38(3), pages 259-267, March.
    174. Sung Eun Choi & Seth A. Berkowitz & John S. Yudkin & Huseyin Naci & Sanjay Basu, 2019. "Personalizing Second-Line Type 2 Diabetes Treatment Selection: Combining Network Meta-analysis, Individualized Risk, and Patient Preferences for Unified Decision Support," Medical Decision Making, , vol. 39(3), pages 239-252, April.
    175. Klas Kellerborg & Werner Brouwer & Pieter Baal, 2020. "Costs and benefits of interventions aimed at major infectious disease threats: lessons from the literature," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(9), pages 1329-1350, December.
    176. Manal H. El-Hamamsy & Gihan H. Elsisi & Randa Eldessouki & Mohamed M. Elmazar & Ahmed S. Taha & Basma F. Awad & Hossam Elmansy, 2016. "Economic Evaluation of the Combined Use of Warfarin and Low-dose Aspirin Versus Warfarin Alone in Mechanical Valve Prostheses," Applied Health Economics and Health Policy, Springer, vol. 14(4), pages 431-440, August.
    177. Simon Frey & Carl R. Blankart & Tom Stargardt, 2016. "Economic Burden and Quality-of-Life Effects of Chronic Lymphocytic Leukemia: A Systematic Review of the Literature," PharmacoEconomics, Springer, vol. 34(5), pages 479-498, May.
    178. Laura Pizzi & Neil Seligman & Jason Baxter & Eric Jutkowitz & Vincenzo Berghella, 2014. "Cost and Cost Effectiveness of Vaginal Progesterone Gel in Reducing Preterm Birth: An Economic Analysis of the PREGNANT Trial," PharmacoEconomics, Springer, vol. 32(5), pages 467-478, May.
    179. Björn Stollenwerk & Sergio Iannazzo & Ron Akehurst & Michael Adena & Andrew Briggs & Bastian Dehmel & Patrick Parfrey & Vasily Belozeroff, 2018. "A Decision-Analytic Model to Assess the Cost-Effectiveness of Etelcalcetide vs. Cinacalcet," PharmacoEconomics, Springer, vol. 36(5), pages 603-612, May.
    180. Marita Mann & Assegid Mengistu & Johannes Gaeseb & Evans Sagwa & Greatjoy Mazibuko & Joseph B. Babigumira & Louis P. Garrison & Andy Stergachis, 2016. "Active Surveillance versus Spontaneous Reporting for First-Line Antiretroviral Medicines in Namibia: A Cost–Utility Analysis," Drug Safety, Springer, vol. 39(9), pages 859-872, September.
    181. Helen Weatherly & Rita Faria & Bernard Van den Berg & Mark Sculpher & Peter O’Neill & Kay Nolan & Julie Glanville & Jaana Isojarvi & Erin Baragula & Mary Edwards, 2017. "Scoping review on social care economic evaluation methods," Working Papers 150cherp, Centre for Health Economics, University of York.
    182. Georgina Jones & Victoria Brennan & Richard Jacques & Hilary Wood & Simon Dixon & Stephen Radley, 2018. "Evaluating the impact of a ‘virtual clinic’ on patient experience, personal and provider costs of care in urinary incontinence: A randomised controlled trial," PLOS ONE, Public Library of Science, vol. 13(1), pages 1-16, January.
    183. Donghoon Lee & Ye-Rin Lee & In-Hwan Oh, 2019. "Cost-effectiveness of smoking cessation programs for hospitalized patients: a systematic review," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(9), pages 1409-1424, December.
    184. Edward Wilson & Ludmila Shulgina & Anthony Cahn & Edwin Chilvers & Helen Parfrey & Allan Clark & Orion Twentyman & Andrew Wilson, 2014. "Treating Idiopathic Pulmonary Fibrosis with the Addition of Co-Trimoxazole: An Economic Evaluation Alongside a Randomised Controlled Trial," PharmacoEconomics, Springer, vol. 32(1), pages 87-99, January.
    185. Robbin H Ophuis & Joran Lokkerbol & Mickaël Hiligsmann & Silvia M A A Evers, 2018. "Early intervention for subthreshold panic disorder in the Netherlands: A model-based economic evaluation from a societal perspective," PLOS ONE, Public Library of Science, vol. 13(2), pages 1-14, February.
    186. El-Banna, Asmaa & Petrou, Stavros & Yiu, Hei Hang Edmund & Daher, Shahd & Forrester, Donald & Scourfield, Jonathan & Wilkins, David & Evans, Rhiannon & Turley, Ruth & Wallace, Sarah, 2021. "Systematic review of economic evaluations of children’s social care interventions," Children and Youth Services Review, Elsevier, vol. 121(C).
    187. Padam Kanta Dahal & Lal B. Rawal & Rashidul Alam Mahumud & Grish Paudel & Tomohiko Sugishita & Corneel Vandelanotte, 2022. "Economic Evaluation of Health Behavior Interventions to Prevent and Manage Type 2 Diabetes Mellitus in Asia: A Systematic Review of Randomized Controlled Trials," IJERPH, MDPI, vol. 19(17), pages 1-20, August.
    188. Inigo Bermejo & Paul Tappenden & Ji-Hee Youn, 2017. "Response to ‘Comment on “Replicating Health Economic Models: Firm Foundations or a House of Cards?”’," PharmacoEconomics, Springer, vol. 35(11), pages 1189-1190, November.
    189. Hedwig Blommestein & Margreet Franken & Carin Uyl-de Groot, 2015. "A Practical Guide for Using Registry Data to Inform Decisions About the Cost Effectiveness of New Cancer Drugs: Lessons Learned from the PHAROS Registry," PharmacoEconomics, Springer, vol. 33(6), pages 551-560, June.
    190. David Brain & Ruth Tulleners & Xing Lee & Qinglu Cheng & Nicholas Graves & Rosana Pacella, 2019. "Cost-effectiveness analysis of an innovative model of care for chronic wounds patients," PLOS ONE, Public Library of Science, vol. 14(3), pages 1-13, March.
    191. Rachael Taylor & Deborah Sullivan & Penny Reeves & Nicola Kerr & Amy Sawyer & Emma Schwartzkoff & Andrew Bailey & Christopher Williams & Alexis Hure, 2023. "A Scoping Review of Economic Evaluations to Inform the Reorientation of Preventive Health Services in Australia," IJERPH, MDPI, vol. 20(12), pages 1-47, June.
    192. Pablo Romero-Sanchiz & Raquel Nogueira-Arjona & Antonio García-Ruiz & Juan V Luciano & Javier García Campayo & Margalida Gili & Cristina Botella & Rosa Baños & Adoración Castro & Yolanda López-Del-Hoy, 2017. "Economic evaluation of a guided and unguided internet-based CBT intervention for major depression: Results from a multi-center, three-armed randomized controlled trial conducted in primary care," PLOS ONE, Public Library of Science, vol. 12(2), pages 1-15, February.
    193. Muhammad Hamza & Maryam A Idris & Musa B Maiyaki & Mohammed Lamorde & Jean-Philippe Chippaux & David A Warrell & Andreas Kuznik & Abdulrazaq G Habib, 2016. "Cost-Effectiveness of Antivenoms for Snakebite Envenoming in 16 Countries in West Africa," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 10(3), pages 1-16, March.
    194. Stephen Mac & Ryan O’Reilly & Neill K J Adhikari & Robert Fowler & Beate Sander, 2020. "Point-of-care diagnostic tests for influenza in the emergency department: A cost-effectiveness analysis in a high-risk population from a Canadian perspective," PLOS ONE, Public Library of Science, vol. 15(11), pages 1-15, November.
    195. Francisco Jódar-Sánchez & Amaia Malet-Larrea & José Martín & Leticia García-Mochón & M. López del Amo & Fernando Martínez-Martínez & Miguel Gastelurrutia-Garralda & Victoria García-Cárdenas & Daniel S, 2015. "Cost-Utility Analysis of a Medication Review with Follow-Up Service for Older Adults with Polypharmacy in Community Pharmacies in Spain: The conSIGUE Program," PharmacoEconomics, Springer, vol. 33(6), pages 599-610, June.
    196. Seungman Cha & Sunghoon Jung & Dawit Belew Bizuneh & Tadesse Abera & Young-Ah Doh & Jieun Seong & Ian Ross, 2020. "Benefits and Costs of a Community-Led Total Sanitation Intervention in Rural Ethiopia—A Trial-Based Ex Post Economic Evaluation," IJERPH, MDPI, vol. 17(14), pages 1-21, July.
    197. Paola Salari & Thomas Fürst & Stefanie Knopp & Jürg Utzinger & Fabrizio Tediosi, 2020. "Cost of interventions to control schistosomiasis: A systematic review of the literature," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 14(3), pages 1-23, March.
    198. Andrew Gallagher & Violetta Shersher & Duncan Mortimer & Helen Truby & Terry Haines, 2023. "The Cost-Effectiveness of Adjunctive Lifestyle Interventions for the Management of Cancer: A Systematic Review," Applied Health Economics and Health Policy, Springer, vol. 21(2), pages 225-242, March.
    199. Fei Yang & Meixia Liao & Pusheng Wang & Zheng Yang & Yongguang Liu, 2021. "The Cost-Effectiveness of Kidney Replacement Therapy Modalities: A Systematic Review of Full Economic Evaluations," Applied Health Economics and Health Policy, Springer, vol. 19(2), pages 163-180, March.
    200. César Ramos Rocha-Filho & Johnny Wallef Leite Martins & Rosa Camila Lucchetta & Gabriel Sodré Ramalho & Giulia Fernandes Moça Trevisani & Aline Pereira da Rocha & Ana Carolina Pereira Nunes Pinto & Fe, 2022. "Hospitalization costs of coronaviruses diseases in upper-middle-income countries: A systematic review," PLOS ONE, Public Library of Science, vol. 17(3), pages 1-13, March.
    201. Margreet S H Wortman & Joran Lokkerbol & Johannes C van der Wouden & Bart Visser & Henriëtte E van der Horst & Tim C olde Hartman, 2018. "Cost-effectiveness of interventions for medically unexplained symptoms: A systematic review," PLOS ONE, Public Library of Science, vol. 13(10), pages 1-23, October.
    202. Przemysław Holko & Paweł Kawalec & Andrzej Pilc, 2018. "Cost-Effectiveness Analysis of Crohn’s Disease Treatment with Vedolizumab and Ustekinumab After Failure of Tumor Necrosis Factor-α Antagonist," PharmacoEconomics, Springer, vol. 36(7), pages 853-865, July.
    203. Jean Christophe Fotso & Ashley Ambrose & Paul Hutchinson & Disha Ali, 2020. "Improving maternal and newborn care: cost-effectiveness of an innovation to rebrand traditional birth attendants in Sierra Leone," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 65(9), pages 1603-1612, December.
    204. Christopher James Sampson & Tim Wrightson, 2017. "Model Registration: A Call to Action," PharmacoEconomics - Open, Springer, vol. 1(2), pages 73-77, June.
    205. Susanne Mayer & Noemi Kiss & Agata Łaszewska & Judit Simon, 2017. "Costing evidence for health care decision-making in Austria: A systematic review," PLOS ONE, Public Library of Science, vol. 12(8), pages 1-18, August.
    206. Nicole T A Rosendaal & Marleen E Hendriks & Mark D Verhagen & Oladimeji A Bolarinwa & Emmanuel O Sanya & Philip M Kolo & Peju Adenusi & Kayode Agbede & Diederik van Eck & Siok Swan Tan & Tanimola M Ak, 2016. "Costs and Cost-Effectiveness of Hypertension Screening and Treatment in Adults with Hypertension in Rural Nigeria in the Context of a Health Insurance Program," PLOS ONE, Public Library of Science, vol. 11(6), pages 1-20, June.
    207. K. Achtert & L. Kerkemeyer, 2021. "The economic burden of amyotrophic lateral sclerosis: a systematic review," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(8), pages 1151-1166, November.
    208. Thomas Davidson & Eva-Karin Bergström & Magnus Husberg & Ulla Moberg Sköld, 2022. "Long-Term Cost-Effectiveness through the Dental-Health FRAMM Guideline for Caries Prevention," IJERPH, MDPI, vol. 19(4), pages 1-10, February.
    209. Zuzana Špacírová & David Epstein & Leticia García-Mochón & Joan Rovira & Antonio Olry de Labry Lima & Jaime Espín, 2020. "A general framework for classifying costing methods for economic evaluation of health care," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(4), pages 529-542, June.
    210. Ewa Stawowczyk & Paweł Kawalec, 2018. "A Systematic Review of the Cost-Effectiveness of Biologics for Ulcerative Colitis," PharmacoEconomics, Springer, vol. 36(4), pages 419-434, April.
    211. Blythe Adamson & Dobromir Dimitrov & Beth Devine & Ruanne Barnabas, 2017. "The Potential Cost-Effectiveness of HIV Vaccines: A Systematic Review," PharmacoEconomics - Open, Springer, vol. 1(1), pages 1-12, March.
    212. Silvia F Hope & Jacqui Webster & Kathy Trieu & Arti Pillay & Merina Ieremia & Colin Bell & Wendy Snowdon & Bruce Neal & Marj Moodie, 2017. "A systematic review of economic evaluations of population-based sodium reduction interventions," PLOS ONE, Public Library of Science, vol. 12(3), pages 1-22, March.
    213. J. Caro & Jörgen Möller, 2014. "Decision-Analytic Models: Current Methodological Challenges," PharmacoEconomics, Springer, vol. 32(10), pages 943-950, October.
    214. Clara Marquina & Ella Zomer & Sandra Vargas-Torres & Sophia Zoungas & Richard Ofori-Asenso & Danny Liew & Zanfina Ademi, 2020. "Novel Treatment Strategies for Secondary Prevention of Cardiovascular Disease: A Systematic Review of Cost-Effectiveness," PharmacoEconomics, Springer, vol. 38(10), pages 1095-1113, October.
    215. Chloé Gervès-Pinquié & Anne Girault & Serena Phillips & Sarah Raskin & Mandi Pratt-Chapman, 2018. "Economic evaluation of patient navigation programs in colorectal cancer care, a systematic review," Health Economics Review, Springer, vol. 8(1), pages 1-12, December.
    216. Katarina Lauruschkus & Johan Jarl & Katharina Fasth Gillstedt & Åsa B. Tornberg, 2022. "Dynamic Standing Exercise in a Novel Assistive Device Compared with Standard Care for Children with Cerebral Palsy Who Are Non-Ambulant, with Regard to Quality of Life and Cost-Effectiveness," Disabilities, MDPI, vol. 2(1), pages 1-13, January.
    217. Samuel Herzog & Marian Shanahan & Peter Grimison & Anh Tran & Nicole Wong & Nicholas Lintzeris & John Simes & Martin Stockler & Rachael L. Morton, 2018. "Systematic Review of the Costs and Benefits of Prescribed Cannabis-Based Medicines for the Management of Chronic Illness: Lessons from Multiple Sclerosis," PharmacoEconomics, Springer, vol. 36(1), pages 67-78, January.
    218. Irina Odnoletkova & Dirk Ramaekers & Frank Nobels & Geert Goderis & Bert Aertgeerts & Lieven Annemans, 2016. "Delivering Diabetes Education through Nurse-Led Telecoaching. Cost-Effectiveness Analysis," PLOS ONE, Public Library of Science, vol. 11(10), pages 1-18, October.
    219. Susan Horton & Hellen Gelband & Dean Jamison & Carol Levin & Rachel Nugent & David Watkins, 2017. "Ranking 93 health interventions for low- and middle-income countries by cost-effectiveness," PLOS ONE, Public Library of Science, vol. 12(8), pages 1-12, August.
    220. Carlene S. Starck & Michelle Blumfield & Tim Keighley & Skye Marshall & Peter Petocz & Elif Inan-Eroglu & Kylie Abbott & Tim Cassettari & Ajmol Ali & Carol Wham & Rozanne Kruger & Geoff Kira & Flavia , 2021. "Nutrient Dense, Low-Cost Foods Can Improve the Affordability and Quality of the New Zealand Diet—A Substitution Modeling Study," IJERPH, MDPI, vol. 18(15), pages 1-22, July.
    221. Rita Bosetti & Laila Tabatabai & Georges Naufal & Terri Menser & Bita Kash, 2021. "Comprehensive cost-effectiveness of diabetes management for the underserved in the United States: A systematic review," PLOS ONE, Public Library of Science, vol. 16(11), pages 1-19, November.
    222. Fiammetta M. Bozzani & Fern Terris-Prestholt & Matthew Quaife & Mitzy Gafos & Pitchaya P. Indravudh & Rebecca Giddings & Graham F. Medley & Shelly Malhotra & Sergio Torres-Rueda, 2023. "Costs and Cost-Effectiveness of Biomedical, Non-Surgical HIV Prevention Interventions: A Systematic Literature Review," PharmacoEconomics, Springer, vol. 41(5), pages 467-480, May.
    223. Kinchin, Irina & Jacups, Susan & Hunter, Gary & Rogerson, Bernadette, 2016. "Economic evaluation of ‘Return to Country’: A remote Australian initiative to address indigenous homelessness," Evaluation and Program Planning, Elsevier, vol. 56(C), pages 69-75.
    224. Alexander V van Schoonhoven & Judith J Gout-Zwart & Marijke J S de Vries & Antoinette D I van Asselt & Evgeni Dvortsin & Pepijn Vemer & Job F M van Boven & Maarten J Postma, 2019. "Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands: A systematic review," PLOS ONE, Public Library of Science, vol. 14(9), pages 1-22, September.
    225. Carla Rognoni & Alessandro Furnari & Marzia Lugli & Oscar Maleti & Alessandro Greco & Rosanna Tarricone, 2023. "Time-Driven Activity-Based Costing for Capturing the Complexity of Healthcare Processes: The Case of Deep Vein Thrombosis and Leg Ulcers," IJERPH, MDPI, vol. 20(10), pages 1-16, May.
    226. Laura Amanda Vallejo-Aparicio & Jesús Molina & Iñigo Ojanguren & Ana Viejo Casas & Alicia Huerta & Henrik Svedsater, 2020. "Cost–consequence analysis of fluticasone furoate/vilanterol for asthma management in Spain: an analysis based on the Salford Lung Study in asthma," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(1), pages 7-17, February.
    227. Ka Keat Lim & Sook Yee Yoon & Nur Aishah Mohd Taib & Fatiha Hana Shabaruddin & Maznah Dahlui & Yin Ling Woo & Meow Keong Thong & Soo Hwang Teo & Nathorn Chaiyakunapruk, 2018. "Is BRCA Mutation Testing Cost Effective for Early Stage Breast Cancer Patients Compared to Routine Clinical Surveillance? The Case of an Upper Middle-Income Country in Asia," Applied Health Economics and Health Policy, Springer, vol. 16(3), pages 395-406, June.
    228. Kathrin Steinbeisser & Larissa Schwarzkopf & Elmar Graessel & Hildegard Seidl, 2020. "Cost-effectiveness of a non-pharmacological treatment vs. “care as usual” in day care centers for community-dwelling older people with cognitive impairment: results from the German randomized controll," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(6), pages 825-844, August.
    229. Hendrik Koffijberg & Claire Rothery & Kalipso Chalkidou & Janneke Grutters, 2018. "Value of Information Choices that Influence Estimates: A Systematic Review of Prevailing Considerations," Medical Decision Making, , vol. 38(7), pages 888-900, October.
    230. Joanna Emerson & Ari Panzer & Joshua T Cohen & Kalipso Chalkidou & Yot Teerawattananon & Mark Sculpher & Thomas Wilkinson & Damian Walker & Peter J Neumann & David D Kim, 2019. "Adherence to the iDSI reference case among published cost-per-DALY averted studies," PLOS ONE, Public Library of Science, vol. 14(5), pages 1-13, May.
    231. Don Husereau & Brian Feagan & Carl Selya-Hammer, 2018. "Policy Options for Infliximab Biosimilars in Inflammatory Bowel Disease Given Emerging Evidence for Switching," Applied Health Economics and Health Policy, Springer, vol. 16(3), pages 279-288, June.
    232. Magnus Zingmark & Ingeborg Nilsson & Fredrik Norström & Klas Göran Sahlén & Lars Lindholm, 2017. "Cost effectiveness of an intervention focused on reducing bathing disability," European Journal of Ageing, Springer, vol. 14(3), pages 233-241, September.
    233. Matthew R Behrend & María-Gloria Basáñez & Jonathan I D Hamley & Travis C Porco & Wilma A Stolk & Martin Walker & Sake J de Vlas & for the NTD Modelling Consortium, 2020. "Modelling for policy: The five principles of the Neglected Tropical Diseases Modelling Consortium," PLOS Neglected Tropical Diseases, Public Library of Science, vol. 14(4), pages 1-17, April.
    234. Jaclyn Beca & Don Husereau & Kelvin K. W. Chan & Neil Hawkins & Jeffrey S. Hoch, 2018. "Oncology Modeling for Fun and Profit! Key Steps for Busy Analysts in Health Technology Assessment," PharmacoEconomics, Springer, vol. 36(1), pages 7-15, January.
    235. Paul Jülicher & Vladimir P Chulanov & Nikolay N Pimenov & Ekaterina Chirkova & Anna Yankina & Claudio Galli, 2019. "Streamlining the screening cascade for active Hepatitis C in Russia: A cost-effectiveness analysis," PLOS ONE, Public Library of Science, vol. 14(7), pages 1-22, July.
    236. Jeroen T J M van Dijck & Mark D Dijkman & Robbin H Ophuis & Godard C W de Ruiter & Wilco C Peul & Suzanne Polinder, 2019. "In-hospital costs after severe traumatic brain injury: A systematic review and quality assessment," PLOS ONE, Public Library of Science, vol. 14(5), pages 1-21, May.
    237. Yulia Anopa & Alex D McMahon & David I Conway & Graham E Ball & Emma McIntosh & Lorna M D Macpherson, 2015. "Improving Child Oral Health: Cost Analysis of a National Nursery Toothbrushing Programme," PLOS ONE, Public Library of Science, vol. 10(8), pages 1-18, August.
    238. Ramin Ravangard & Farideh Sadat Jalali & Marjan Hajahmadi & Abdosaleh Jafari, 2023. "Cost-utility analysis of valsartan, enalapril, and candesartan in patients with heart failure in Iran," Health Economics Review, Springer, vol. 13(1), pages 1-11, December.
    239. Patrícia Coelho de Soárez & Ana Marli Christovam Sartori & Angela Carvalho Freitas & Álvaro Mitsunori Nishikawa & Hillegonda Maria Dutilh Novaes, 2015. "Cost-Effectiveness Analysis of Universal Vaccination of Adults Aged 60 Years with 23-Valent Pneumococcal Polysaccharide Vaccine versus Current Practice in Brazil," PLOS ONE, Public Library of Science, vol. 10(6), pages 1-15, June.
    240. Mohamed El Alili & Johanna M. Dongen & Judith A. F. Huirne & Maurits W. Tulder & Judith E. Bosmans, 2017. "Reporting and Analysis of Trial-Based Cost-Effectiveness Evaluations in Obstetrics and Gynaecology," PharmacoEconomics, Springer, vol. 35(10), pages 1007-1033, October.
    241. Naomi Lince-Deroche & Jane Phiri & Pam Michelow & Jennifer S Smith & Cindy Firnhaber, 2015. "Costs and Cost Effectiveness of Three Approaches for Cervical Cancer Screening among HIV-Positive Women in Johannesburg, South Africa," PLOS ONE, Public Library of Science, vol. 10(11), pages 1-16, November.
    242. Neily Zakiyah & Maarten Postma & Philip Baker & Antoinette Asselt, 2015. "Pre-eclampsia Diagnosis and Treatment Options: A Review of Published Economic Assessments," PharmacoEconomics, Springer, vol. 33(10), pages 1069-1082, October.
    243. Caroline M. Vass & Katherine Payne, 2017. "Using Discrete Choice Experiments to Inform the Benefit-Risk Assessment of Medicines: Are We Ready Yet?," PharmacoEconomics, Springer, vol. 35(9), pages 859-866, September.
    244. Jinsong Geng & Hao Yu & Yiwei Mao & Peng Zhang & Yingyao Chen, 2015. "Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes," PharmacoEconomics, Springer, vol. 33(6), pages 581-597, June.
    245. Léa Duchesne & Gilles Hejblum & Richard Njouom & Coumba Touré Kane & Thomas d’Aquin Toni & Raoul Moh & Babacar Sylla & Nicolas Rouveau & Alain Attia & Karine Lacombe, 2020. "Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in Central and Western Africa," PLOS ONE, Public Library of Science, vol. 15(8), pages 1-18, August.
    246. Angela Devine & Alice Vahanian & Bernard Sawadogo & Souleymane Zan & Fadima Yaya Bocoum & Helen Kelly & Clare Gilham & Nicolas Nagot & Jason Ong & Rosa Legood & Nicolas Meda & Alec Miners & Philippe M, 2021. "Costs and cost-effectiveness of cervical cancer screening strategies in women living with HIV in Burkina Faso: The HPV in Africa Research Partnership (HARP) study," Post-Print hal-03554345, HAL.
    247. Fred Hellinger, 2013. "Assessing the Cost Effectiveness of Pre-Exposure Prophylaxis for HIV Prevention in the US," PharmacoEconomics, Springer, vol. 31(12), pages 1091-1104, December.
    248. Alessandro G. Campolina & Luciana M. Rozman & Tassia C. Decimoni & Roseli Leandro & Hillegonda M. D. Novaes & Patrícia Coelho De Soárez, 2017. "Many Miles to Go: A Systematic Review of the State of Cost-Utility Analyses in Brazil," Applied Health Economics and Health Policy, Springer, vol. 15(2), pages 163-172, April.
    249. Alena M Pfeil & Oliver Reich & Ines M Guerra & Sandrine Cure & Francesco Negro & Beat Müllhaupt & Daniel Lavanchy & Matthias Schwenkglenks, 2015. "Cost-Effectiveness Analysis of Sofosbuvir Compared to Current Standard Treatment in Swiss Patients with Chronic Hepatitis C," PLOS ONE, Public Library of Science, vol. 10(5), pages 1-20, May.
    250. Sedona Sweeney & Anna Vassall & Nicola Foster & Victoria Simms & Patrick Ilboudo & Godfather Kimaro & Don Mudzengi & Lorna Guinness, 2016. "Methodological Issues to Consider When Collecting Data to Estimate Poverty Impact in Economic Evaluations in Low‐income and Middle‐income Countries," Health Economics, John Wiley & Sons, Ltd., vol. 25(S1), pages 42-52, February.
    251. Thomas Grochtdreis & Christian Brettschneider & Annemarie Wegener & Birgit Watzke & Steffi Riedel-Heller & Martin Härter & Hans-Helmut König, 2015. "Cost-Effectiveness of Collaborative Care for the Treatment of Depressive Disorders in Primary Care: A Systematic Review," PLOS ONE, Public Library of Science, vol. 10(5), pages 1-20, May.
    252. Katharina M. D. Merollini & Louisa G. Gordon & Joanne F. Aitken & Michael G. Kimlin, 2020. "Lifetime Costs of Surviving Cancer—A Queensland Study (COS-Q): Protocol of a Large Healthcare Data Linkage Study," IJERPH, MDPI, vol. 17(8), pages 1-16, April.
    253. Joan Mendivil & Marilena Appierto & Susana Aceituno & Mercè Comas & Montserrat Rué, 2019. "Economic evaluations of screening strategies for the early detection of colorectal cancer in the average-risk population: A systematic literature review," PLOS ONE, Public Library of Science, vol. 14(12), pages 1-18, December.
    254. Mattias Neyt & Joan Vlayen & Stephan Devriese & Cécile Camberlin, 2018. "First- and second-line bevacizumab in ovarian cancer: A Belgian cost-utility analysis," PLOS ONE, Public Library of Science, vol. 13(4), pages 1-16, April.
    255. Carmen Selva-Sevilla & F Dámaso Fernández-Ginés & Manuel Cortiñas-Sáenz & Manuel Gerónimo-Pardo, 2021. "Cost-effectiveness analysis of domiciliary topical sevoflurane for painful leg ulcers," PLOS ONE, Public Library of Science, vol. 16(9), pages 1-18, September.
    256. Haiying Ding & Wenxiu Xin & Yinghui Tong & Jiao Sun & Gaoqi Xu & Ziqi Ye & Yuefeng Rao, 2020. "Cost effectiveness of immune checkpoint inhibitors for treatment of non-small cell lung cancer: A systematic review," PLOS ONE, Public Library of Science, vol. 15(9), pages 1-16, September.
    257. Nikita M. John & Stuart J. Wright & Sean P. Gavan & Caroline M. Vass, 2019. "The role of information provision in economic evaluations of non-invasive prenatal testing: a systematic review," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(8), pages 1123-1131, November.
    258. Natalie Carvalho & Mark Jit & Sarah Cox & Joanne Yoong & Raymond C. W. Hutubessy, 2018. "Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Frame," PharmacoEconomics, Springer, vol. 36(1), pages 79-90, January.
    259. Irina A. Tikhonova & Martin W. Hoyle & Tristan M. Snowsill & Chris Cooper & Joanna L. Varley-Campbell & Claudius E. Rudin & Ruben E. Mujica Mota, 2017. "Azacitidine for Treating Acute Myeloid Leukaemia with More Than 30 % Bone Marrow Blasts: An Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology A," PharmacoEconomics, Springer, vol. 35(3), pages 363-373, March.
    260. Marufa Sultana & Abdur Razzaque Sarker & Nausad Ali & Raisul Akram & Lisa Gold, 2019. "Economic evaluation of community acquired pneumonia management strategies: A systematic review of literature," PLOS ONE, Public Library of Science, vol. 14(10), pages 1-21, October.
    261. Daniel M. Sugrue & Thomas Ward & Sukhvir Rai & Phil McEwan & Heleen G. M. Haalen, 2019. "Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model Design," PharmacoEconomics, Springer, vol. 37(12), pages 1451-1468, December.
    262. Naomi Lince-Deroche & Craig van Rensburg & Jaqueline Roseleur & Busola Sanusi & Jane Phiri & Pam Michelow & Jennifer S Smith & Cindy Firnhaber, 2018. "Costs and cost-effectiveness of LEEP versus cryotherapy for treating cervical dysplasia among HIV-positive women in Johannesburg, South Africa," PLOS ONE, Public Library of Science, vol. 13(10), pages 1-13, October.
    263. C. Rinciog & M. Watkins & S. Chang & T. M. Maher & C. LeReun & D. Esser & A. Diamantopoulos, 2017. "A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK," PharmacoEconomics, Springer, vol. 35(4), pages 479-491, April.
    264. Colin H. Ridyard & Dyfrig A. Hughes & DIRUM Team, 2015. "Taxonomy for Methods of Resource Use Measurement," Health Economics, John Wiley & Sons, Ltd., vol. 24(3), pages 372-378, March.
    265. Mikyung Kelly Seo & John Cairns, 2018. "Do cancer biomarkers make targeted therapies cost-effective? A systematic review in metastatic colorectal cancer," PLOS ONE, Public Library of Science, vol. 13(9), pages 1-23, September.
    266. A-La Park & Eui-Hyoung Hwang & Man-Suk Hwang & In Heo & Sun-Young Park & Jun-Hwan Lee & In-Hyuk Ha & Jae-Heung Cho & Byung-Cheul Shin, 2021. "Cost-Effectiveness of Chuna Manual Therapy and Usual Care, Compared with Usual Care Only for People with Neck Pain following Traffic Accidents: A Multicenter Randomized Controlled Trial," IJERPH, MDPI, vol. 18(19), pages 1-13, September.
    267. Gerardus Frederix & Hossein Haji Ali Afzali & Erik Dasbach & Robyn Ward, 2015. "Development and Use of Disease-Specific (Reference) Models for Economic Evaluations of Health Technologies: An Overview of Key Issues and Potential Solutions," PharmacoEconomics, Springer, vol. 33(8), pages 777-781, August.
    268. Reyes Lorente & Fernando Antonanzas, 2022. "Seeking efficiency gains outside drugs and diagnostics," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(5), pages 759-761, July.
    269. Stavros Petrou & Kamran Khan, 2013. "An Overview of the Health Economic Implications of Elective Caesarean Section," Applied Health Economics and Health Policy, Springer, vol. 11(6), pages 561-576, December.
    270. Cynthia P. Iglesias & Alexander Thompson & Wolf H. Rogowski & Katherine Payne, 2016. "Reporting Guidelines for the Use of Expert Judgement in Model-Based Economic Evaluations," PharmacoEconomics, Springer, vol. 34(11), pages 1161-1172, November.
    271. Rashidul Alam Mahumud & Khorshed Alam & Syed Afroz Keramat & Gail M Ormsby & Jeff Dunn & Jeff Gow, 2020. "Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review," PLOS ONE, Public Library of Science, vol. 15(6), pages 1-15, June.
    272. Martin Howell & Rachael C. Walker & Kirsten Howard, 2019. "Cost Effectiveness of Dialysis Modalities: A Systematic Review of Economic Evaluations," Applied Health Economics and Health Policy, Springer, vol. 17(3), pages 315-330, June.
    273. Simone A. Huygens & Isaac Corro Ramos & Carlijn V. C. Bouten & Jolanda Kluin & Shih Ting Chiu & Gary L. Grunkemeier & Johanna J. M. Takkenberg & Maureen P. M. H. Rutten-van Mölken, 2020. "Early cost-utility analysis of tissue-engineered heart valves compared to bioprostheses in the aortic position in elderly patients," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(4), pages 557-572, June.
    274. Steffen Flessa & Dominik Dietz & Elisabete Weiderpass, 2016. "Health policy support under extreme uncertainty: the case of cervical cancer in Cambodia," EURO Journal on Decision Processes, Springer;EURO - The Association of European Operational Research Societies, vol. 4(3), pages 183-218, November.
    275. Naseem Cassim & Kathryn Schnippel & Lindi Marie Coetzee & Deborah Kim Glencross, 2017. "Establishing a cost-per-result of laboratory-based, reflex Cryptococcal antigenaemia screening (CrAg) in HIV+ patients with CD4 counts less than 100 cells/μl using a Lateral Flow Assay (LFA) at a typi," PLOS ONE, Public Library of Science, vol. 12(2), pages 1-12, February.
    276. Laura Burgers & William Redekop & Johan Severens, 2014. "Challenges in Modelling the Cost Effectiveness of Various Interventions for Cardiovascular Disease," PharmacoEconomics, Springer, vol. 32(7), pages 627-637, July.
    277. S. W. Quist & A. J. Postma & K. J. Myrén & L. A. Jong & M. J. Postma, 2023. "Cost-effectiveness of ravulizumab compared with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria in the Netherlands," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(9), pages 1455-1472, December.
    278. Qinglu Cheng & Nicholas Graves & Rosana E. Pacella, 2018. "Economic Evaluations of Guideline-Based Care for Chronic Wounds: a Systematic Review," Applied Health Economics and Health Policy, Springer, vol. 16(5), pages 633-651, October.
    279. Ben Kearns & Roberta Ara & Allan Wailoo & Andrea Manca & Monica Alava & Keith Abrams & Mike Campbell, 2013. "Good Practice Guidelines for the use of Statistical Regression Models in Economic Evaluations," PharmacoEconomics, Springer, vol. 31(8), pages 643-652, August.
    280. Gabriel Tremblay & Clemence Cariou & Christian Recher & Mike Dolph & Patricia Brandt & Anne-Sandrine Blanc & Anna Forsythe, 2020. "Cost-effectiveness of midostaurin in the treatment of newly diagnosed FLT3-mutated acute myeloid leukemia in France," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(4), pages 543-555, June.
    281. Leticia García-Mochón & Zuzana Špacírová & Jaime Espín, 2022. "Costing methodologies in European economic evaluation guidelines: commonalities and divergences," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(6), pages 979-991, August.
    282. Sampaio, Filipa & Ssegonja, Richard & Thiblin, Ingemar & Nystrand, Camilla, 2021. "A model for evaluating the economic value of prevention programs for illicit use of anabolic androgenic steroids," Health Policy, Elsevier, vol. 125(6), pages 807-813.
    283. Kittiphong Thiboonboon & Benjarin Santatiwongchai & Varit Chantarastapornchit & Waranya Rattanavipapong & Yot Teerawattananon, 2016. "A Systematic Review of Economic Evaluation Methodologies Between Resource-Limited and Resource-Rich Countries: A Case of Rotavirus Vaccines," Applied Health Economics and Health Policy, Springer, vol. 14(6), pages 659-672, December.
    284. Paolo A. Cortesi & Lucia S. D’Angiolella & Alessandra Lafranconi & Mariangela Micale & Giancarlo Cesana & Lorenzo G. Mantovani, 2018. "Modern Treatments of Haemophilia: Review of Cost-Effectiveness Analyses and Future Directions," PharmacoEconomics, Springer, vol. 36(3), pages 263-284, March.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.